prednisone has been researched along with Alveolitis, Fibrosing in 267 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Excerpt | Relevance | Reference |
---|---|---|
"A combination of prednisone, azathioprine, and N-acetylcysteine (NAC) has been widely used as a treatment for idiopathic pulmonary fibrosis." | 9.16 | Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. ( Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ; Raghu, G, 2012) |
"Therapy with acetylcysteine at a dose of 600 mg three times daily, added to prednisone and azathioprine, preserves vital capacity and DL(CO) in patients with idiopathic pulmonary fibrosis better than does standard therapy alone." | 9.11 | High-dose acetylcysteine in idiopathic pulmonary fibrosis. ( Behr, J; Buhl, R; Capron, F; Corvasce, G; Costabel, U; De Vuyst, P; Dekhuijzen, R; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Montanari, M; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B, 2005) |
"We compared the long-term efficacy of the combination of colchicine and/or D-penicillamine with prednisone, in comparison to prednisone alone in patients with idiopathic pulmonary fibrosis (IPF)." | 9.08 | Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. ( Carrillo, G; Chapela, R; Padilla, RP; Pérez-Chavira, R; Salas, J; Sansores, R; Selman, M, 1998) |
"To determine the long-term efficacy and safety of low-dose methotrexate (MTX) in rheumatoid arthritis (RA)." | 9.07 | Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. ( Coblyn, JS; Falchuk, KR; Fraser, PA; Holdsworth, DE; Maier, AL; Weinblatt, ME; Weissman, BN, 1992) |
"Twenty-seven newly diagnosed patients with idiopathic pulmonary fibrosis (IPF) who were previously untreated for IPF were enrolled in a prospective, double-blind, randomized, placebo-controlled study to compare the therapeutic effect of combined prednisone/azathioprine (n = 14) with prednisone plus placebo (n = 13)." | 9.07 | Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. ( Cain, K; Depaso, WJ; Dreis, DF; Hammar, SP; Hutchinson, J; Pardee, NE; Raghu, G; Wetzel, CE; Winterbauer, RH, 1991) |
"To study the effect of losartan, an angiotensin II antagonist, on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism." | 7.73 | Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. ( Lu, Y; Yao, HW; Zhao, MH; Zhu, JP, 2006) |
"To study the effect of losartan on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism." | 7.71 | [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor]. ( Fang, X; Hu, X; Liu, Y; Zhu, Y, 2002) |
"A six-year experience in 20 patients with advanced mycosis fungoides treated with combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides showed initial complete remissions in 16 patients (85%)." | 7.67 | Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience. ( Thestrup-Pedersen, K; Zachariae, H, 1987) |
"Colchicine appears to be a safer alternative to a trial of high-dose prednisone but may be no different than no therapy." | 6.69 | Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. ( Caron, GM; DeRemee, RA; Douglas, WW; Offord, KP; Ryu, JH; Schroeder, DR; Swensen, SJ, 1998) |
"The prognosis of idiopathic pulmonary fibrosis is poor, it amounts to 4-6 years (after beginning of the symptoms)." | 6.65 | [Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)]. ( Amthor, M; Kronenberger, H; Meier-Sydow, J; Riemann, H; Rust, M; Thiel, C, 1979) |
"Treatment with prednisone again resulted in resolution of all symptoms and normalization of radiographic and hepatic function abnormalities." | 6.38 | Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporine. ( Abbondanzo, SL; Cottler-Fox, M; Deeg, HJ; Raschko, JW; Spitzer, TR; Torrisi, JR, 1989) |
"Colchicine has been reported to suppress fibroblast growth factors and to inhibit collagen deposition." | 5.29 | Colchicine in the treatment of pulmonary fibrosis. ( Coles, DT; DeRemee, RA; Douglas, WW; McDougall, JC; Peters, SG, 1993) |
"A 48-year-old man with systemic lupus erythematosus (SLE) developed disseminated intravascular coagulation (DIC) with clinical bleeding." | 5.27 | Disseminated intravascular coagulation in lupus erythematosus responding to prednisone therapy. ( Riddell, SR; Shojania, AM, 1986) |
"A combination of prednisone, azathioprine, and N-acetylcysteine (NAC) has been widely used as a treatment for idiopathic pulmonary fibrosis." | 5.16 | Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. ( Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ; Raghu, G, 2012) |
"Therapy with acetylcysteine at a dose of 600 mg three times daily, added to prednisone and azathioprine, preserves vital capacity and DL(CO) in patients with idiopathic pulmonary fibrosis better than does standard therapy alone." | 5.11 | High-dose acetylcysteine in idiopathic pulmonary fibrosis. ( Behr, J; Buhl, R; Capron, F; Corvasce, G; Costabel, U; De Vuyst, P; Dekhuijzen, R; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Montanari, M; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B, 2005) |
"We compared the long-term efficacy of the combination of colchicine and/or D-penicillamine with prednisone, in comparison to prednisone alone in patients with idiopathic pulmonary fibrosis (IPF)." | 5.08 | Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. ( Carrillo, G; Chapela, R; Padilla, RP; Pérez-Chavira, R; Salas, J; Sansores, R; Selman, M, 1998) |
"Twenty-seven newly diagnosed patients with idiopathic pulmonary fibrosis (IPF) who were previously untreated for IPF were enrolled in a prospective, double-blind, randomized, placebo-controlled study to compare the therapeutic effect of combined prednisone/azathioprine (n = 14) with prednisone plus placebo (n = 13)." | 5.07 | Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. ( Cain, K; Depaso, WJ; Dreis, DF; Hammar, SP; Hutchinson, J; Pardee, NE; Raghu, G; Wetzel, CE; Winterbauer, RH, 1991) |
"To determine the long-term efficacy and safety of low-dose methotrexate (MTX) in rheumatoid arthritis (RA)." | 5.07 | Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. ( Coblyn, JS; Falchuk, KR; Fraser, PA; Holdsworth, DE; Maier, AL; Weinblatt, ME; Weissman, BN, 1992) |
"Based on available data, partly still unpublished, pirfenidone appears to improve progression-free survival and, to a lesser extent, pulmonary function in patients with idiopathic pulmonary fibrosis." | 4.86 | Non-steroid agents for idiopathic pulmonary fibrosis. ( Balduzzi, S; Cerri, S; D'Amico, R; Del Giovane, C; Luppi, F; Richeldi, L; Spagnolo, P; Walters, EH, 2010) |
"An elderly woman taking 50 mg of nitrofurantoin daily for six months for suppression of recurrent urinary tract infections developed increasing dyspnea and bilateral pulmonary infiltrates." | 4.76 | Nitrofurantoin pulmonary toxicity. ( Hainer, BL; White, AA, 1981) |
"A case of fatal pulmonary fibrosis and atypical epithelial proliferation (AEP) in a patient with multiple myeloma treated with melphalan is presented." | 4.75 | Pulmonary histopathologic changes associated with melphalan therapy. ( Dickman, PS; Feldman, PS; Taetle, R, 1978) |
" The initial outcome is favorable with prednisone and does not seem to lead to pulmonary fibrosis." | 4.31 | Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome. ( Adelaide, L; Ardois, S; Audemard-Verger, A; Bertrand, NM; Bigot, A; Biscay, P; Borie, R; Bouaziz, JD; Bourguiba, R; Constantin, A; de Sainte-Marie, B; Debray, MP; Dieval, C; Duroyon, E; Flamarion, E; Galland, J; Georgin Lavialle, S; Graveleau, J; Groslerons, S; Guedon, AF; Guillotin, V; Heiblig, M; Henneton, P; Humbert, S; Jamilloux, Y; Jeannel, J; Kosmider, O; Kostine, M; Lacombe, V; Lazaro, E; Lobbes, H; Mathian, A; Mekinian, A; Meyer, A; Moulinet, T; Outh, R; Samson, M; Servettaz, A; Templé, M; Terrier, B; Terriou, L; Vial, G; Zakine, E, 2023) |
" We report a case of BRONJ in a patient following six years of oral BP administration for the management of osteoporosis, complicated by four years of prednisone therapy for pulmonary fibrosis." | 3.81 | Risk Factors in the Development of Oral Bisphosphonate-induced Osteonecrosis. ( Reiss, S; Sultan, D, 2015) |
" sinensis and prednisone alleviates pulmonary fibrosis, and the combination use of both drugs has synergia effects in anti-fibrous degeneration." | 3.77 | [Effectiveness of cultured Cordyceps sinensis combined with glucocorticosteroid on pulmonary fibrosis induced by bleomycin in rats]. ( Gu, Y; Li, S; Liao, D; Lin, Y; Liu, R; Xu, H, 2011) |
"To study the effect of losartan, an angiotensin II antagonist, on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism." | 3.73 | Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. ( Lu, Y; Yao, HW; Zhao, MH; Zhu, JP, 2006) |
"To study the effect of losartan on bleomycin-induced pulmonary fibrosis in rats and its possible mechanism." | 3.71 | [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor]. ( Fang, X; Hu, X; Liu, Y; Zhu, Y, 2002) |
"In the following case report the determination of serum lactate dehydrogenase (LDH)-a simple though non-specific test-reflects changes of disease activity and clinical improvement during treatment with cyclophosphamide and a tapered dose of prednisone from 100 to 0 mg daily in a 43-year-old woman with idiopathic pulmonary fibrosis." | 3.69 | Serum LDH: a marker of disease activity and its response to therapy in idiopathic pulmonary fibrosis. ( Cobben, NA; Drent, M; Lamers, RJ; van Dieijen-Visser, MP; van Krugten, M; Wagenaar, SS; Wouters, EF, 1996) |
"A six-year experience in 20 patients with advanced mycosis fungoides treated with combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides showed initial complete remissions in 16 patients (85%)." | 3.67 | Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience. ( Thestrup-Pedersen, K; Zachariae, H, 1987) |
" In two patients with sarcoidosis, a reduction in extravascular lung density occurred after treatment with oral prednisone." | 3.67 | Regional extravascular density and fractional blood volume of the lung in interstitial disease. ( Hughes, JM; Rhodes, CG; Wollmer, P, 1984) |
" We describe 3 consecutive cases complicating dermatomyositis (1 case, anti-Jo-1 antibody negative) and polymyositis (2 cases, anti-Jo-1 antibody positive) in which cyclophosphamide was added to prednisone therapy with favorable outcomes." | 3.67 | Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. ( al-Janadi, M; Karsh, J; Smith, CD, 1989) |
"A patient with ulcerative colitis developed skin allergy to sulfasalazine, manifested by rash urticaria and generalized angioedema." | 3.67 | Sulfasalazine pneumonitis. ( Averbuch, M; Hallak, A; Halpern, Z; Levo, Y; Topilsky, M, 1985) |
"Diffuse interstitial lung disease and pulmonary fibrosis occurred after the use of vindesine and radiation therapy in a patient with squamous cell carcinoma of the lung." | 3.67 | Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung. ( Bott, SJ; Prince-Fiocco, MA; Stewart, FM, 1986) |
"Intersitial pneumonia and pulmonary fibrosis developed in a 72-year-old man during therapy with cyclophosphamide, vincristine, and prednisone." | 3.65 | Cyclophosphamide therapy and interstitial pulmonary fibrosis. ( Patel, AR; Rao, KP; Rhee, HL; Sassoon, H; Shah, PC, 1976) |
"Colchicine appears to be a safer alternative to a trial of high-dose prednisone but may be no different than no therapy." | 2.69 | Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group. ( Caron, GM; DeRemee, RA; Douglas, WW; Offord, KP; Ryu, JH; Schroeder, DR; Swensen, SJ, 1998) |
"No fatal complications or chronic pulmonary fibrosis was seen." | 2.68 | Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment. ( Chap, L; Glaspy, J; Levine, M; Lill, M; Norton, L; Shpiner, R, 1997) |
"Fourteen patients with systemic sclerosis (SSc, scleroderma) and interstitial lung disease were treated with oral cyclophosphamide (1-2 mg/kg/day) and low dose prednisone (< 10 mg/day)." | 2.67 | Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. ( Baumann, MH; Kinsella, MB; Silver, RM; Staudt, LS; Strange, C; Warrick, JH, 1993) |
" Initial dosage was 500 mg, and the dose was escalated provided the total white blood cell count remained > 3,000 cells per cubic millimeter." | 2.67 | Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. ( Baughman, RP; Lower, EE, 1992) |
" A high incidence of side effects occurred, though these do not necessarily prohibit the long term use of cyclosporin A when it is indicated clinically." | 2.67 | Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. ( Bardin, PG; Joubert, JR; Moolman, JA; Rossouw, DJ, 1991) |
"The prognosis of idiopathic pulmonary fibrosis is poor, it amounts to 4-6 years (after beginning of the symptoms)." | 2.65 | [Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)]. ( Amthor, M; Kronenberger, H; Meier-Sydow, J; Riemann, H; Rust, M; Thiel, C, 1979) |
"Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder in which chronic accumulation of neutrophils within the alveolar structures occurs." | 2.65 | Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. ( Bernardo, J; Crystal, RG; Hunninghake, GW; Keogh, BA; Line, BR; Price, DL, 1983) |
"Prednisone has been the mainstay of therapy since its release for clinical use in 1948." | 2.43 | Current perspectives on the treatment of idiopathic pulmonary fibrosis. ( Collard, HR; King, TE; Walter, N, 2006) |
"The treatment of idiopathic pulmonary fibrosis (IPF) remains controversial." | 2.43 | Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach. ( Nathan, SD, 2006) |
"Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia (UIP) is a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with progressively deteriorating respiratory function and ultimately death from respiratory failure." | 2.42 | Immunomodulatory agents for idiopathic pulmonary fibrosis. ( Davies, HR; Richeldi, L; Walters, EH, 2003) |
"Treatment with prednisone again resulted in resolution of all symptoms and normalization of radiographic and hepatic function abnormalities." | 2.38 | Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporine. ( Abbondanzo, SL; Cottler-Fox, M; Deeg, HJ; Raschko, JW; Spitzer, TR; Torrisi, JR, 1989) |
"Bronchiolar emphysema is a rare, insidious, progressive, bilateral pulmonary fibrosis with diffusion defect." | 2.34 | BRONCHIOLAR EMPHYSEMA. A REPORT OF A NECROPSIED CASE OF DIFFUSE BRONCHIOLECTASIS AND REVIEW OF THE LITERATURE. ( JERRY, LM; RITCHIE, AC, 1964) |
"72 Wistar rats were randomly divided into 6 groups: blank control group, model group, prednisone group, Hedysari Radix flavonoids low, medium and high dosage group." | 1.39 | [Effect of flavonoids from hedysari radix on pulmonary functions of pulmonary fibrosis rat]. ( Jing, M; Li, J; Li, JT; Li, XY; Lin, XY; Liu, GW; Liu, YQ; Su, Y; Sun, SB; Zhang, Y, 2013) |
"Idiopathic inflammatory myositis is a challenging group of heterogenous disorders." | 1.39 | Inflammatory myopathies--a review of newly diagnosed patients (2004-2008) in the Counties Manukau region. ( Gow, PJ; Gupta, R, 2013) |
"Interstitial lung disease is a rare but recognised complication of rituximab but has been rarely reported in the setting of ITP." | 1.38 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. ( Berkahn, L; Child, N; O'Carroll, M, 2012) |
"Montelukast-treated rats showed reduction in collagen deposition by 29% and significant reduction in lung hydroxyproline content by 32%." | 1.37 | Effect of leukotriene receptor antagonists on lung fibrosis in rats. ( Shaker, OG; Sourour, DA, 2011) |
"The diagnosis of Wegener's granulomatosis was based on the association of positive antineutrophil cytoplasmic antibodies, urinary sediment abnormalities and renal biopsy findings." | 1.35 | [Pulmonary fibrosis as a presentation of Wegener's granulomatosis]. ( Abid, T; Ayoub, A; Boudawara, T; Gharsalli, H; Kammoun, K; Ketata, W; Makni, S; Mrabet, S; Msaad, S, 2009) |
"Strongyloidiasis is a parasitic disease that can be lethal in immunosuppressed patients especially if lung fibrosis is associated, which has been rarely reported." | 1.32 | [Disseminated strongyloidiasis associated with pulmonary fibrosis and gastrointestinal bleeding]. ( Dao, T; Gloro, R; Le Moel, G; Morin-Fatome, A; Ollivier-Hourmand, I; Rousselot, P, 2004) |
"Interstitial pulmonary fibrosis is a recognized complication of DM, often correlated with antisynthetase enzymes, such as anti-Jo-1." | 1.32 | Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis. ( Cohen, JB; Costner, MI; High, WA; Murphy, BA, 2003) |
"Idiopathic pulmonary fibrosis (IPF) is associated with significant morbidity and mortality despite aggressive therapy." | 1.30 | Idiopathic pulmonary fibrosis: predicting response to therapy and survival. ( Cascade, PN; Flint, A; Gay, SE; Gross, BH; Hyzy, R; Kazerooni, EA; Lynch, JP; Martinez, FJ; Popovich, J; Schork, MA; Spizarny, DL; Toews, GB; Whyte, RI, 1998) |
"Colchicine was well tolerated; few side effects other than mild diarrhea were noted in those patients able to take the drug long enough to return for pulmonary function testing at 3 months." | 1.30 | Colchicine versus prednisone as treatment of usual interstitial pneumonia. ( Bjoraker, JA; DeRemee, RA; Douglas, WW; Myers, JL; Peters, SG; Ryu, JH; Scanlon, PD; Schroeder, DR; Swensen, SJ; Tazelaar, HD, 1997) |
"Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median survival of 3 to 6 yr." | 1.30 | Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. ( Bjoraker, JA; Edwin, MK; Myers, JL; Offord, KP; Ryu, JH; Schroeder, DR; Tazelaar, HD, 1998) |
"Therapies to prevent bone loss and treat established osteoporosis are uncommonly utilized in glucocorticoid-treated patients with end-stage pulmonary disease." | 1.29 | Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. ( Addesso, V; Donovan, D; Jorgesen, B; McGregor, C; Papadopoulos, A; Schulman, L; Shane, E; Silverberg, SJ; Staron, RB, 1996) |
"Colchicine has been reported to suppress fibroblast growth factors and to inhibit collagen deposition." | 1.29 | Colchicine in the treatment of pulmonary fibrosis. ( Coles, DT; DeRemee, RA; Douglas, WW; McDougall, JC; Peters, SG, 1993) |
"Idiopathic pulmonary fibrosis still has to be diagnosed by elimination." | 1.29 | [Treatment of idiopathic pulmonary fibrosis]. ( Nicod, LP, 1995) |
"Idiopathic pulmonary fibrosis (IPF) response to corticosteroids and cytotoxic medications appears to be the most important determinant of survival." | 1.29 | Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis. ( Lafitte, JJ; Marquette, CH; Perez, T; Ramon, P; Tonnel, AB; van Oortegem, K; Wallaert, B, 1994) |
"A 54 year old, postmenopause female with pulmonary fibrosis on steroid therapy is studied for lumbar and sacral pain." | 1.28 | [Spontaneous fracture of the sacrum in patient with pulmonary fibrosis and steroid treatment]. ( Alvarado, A; Guzmán, L; Maluje, V, 1991) |
" Therefore, the patients were given prednisone at an initial dosage of 50-100 mg which was subsequently reduced." | 1.28 | [Persisting alveolitis after Legionella pneumonia]. ( Hürter, T; Lorenz, J; Rumpelt, HJ; Schlegel, J, 1990) |
"The myasthenia gravis was controlled with pyridostigmine." | 1.28 | Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease. ( Atkinson, K; Biggs, J; Bryant, D; Delprado, W, 1989) |
"Prednisone was the drug of choice for therapy." | 1.28 | Management for interstitial lung disease. State of the art. ( Moser, KM; Smith, CM, 1989) |
"Cryptogenic fibrosing alveolitis (CFA) is a relatively uncommon condition with a variable prognosis and a mean survival of less than 5 years." | 1.27 | Cryptogenic fibrosing alveolitis. Clinical spectrum and treatment. ( Bateman, ED; Benatar, SR; Louw, SJ, 1984) |
"Fifteen patients with acute lymphocytic leukemia (ALL) in second or subsequent remission received intensive therapy with cyclophosphamide and single dose, rapid rate (26 cGy/min) total body irradiation (TBI) followed by bone marrow transplantation (BMT) from a histocompatible sibling match." | 1.27 | Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team). ( Goldman, A; Kersey, JH; Kim, TH; Krivit, W; McGlave, PB; Nesbit, ME; Ramsay, NK; Woods, WG, 1983) |
"Six of the seven patients died of pulmonary fibrosis in spite of prednisone treatment." | 1.27 | Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin. ( Eguchi, K; Koketsu, H; Nakajima, T; Niitani, H; Saijo, N; Shibuya, M; Shimabukuro, Z; Shimizu, E; Shinkai, T; Tominaga, K, 1983) |
"A 50-yr-old woman with chronic ulcerative colitis developed severe restrictive lung disease, which progressed after total colectomy and cessation of sulfasalazine therapy." | 1.27 | Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis. ( Kalish, PE; McKee, AL; Pitchumoni, CS; Rajapaksa, A, 1983) |
"Sulfasalazine has been widely used in the treatment of inflammatory bowel disease." | 1.27 | Sulfasalazine-induced pulmonary disease. ( Barwick, KW; DeLuca, VA; Dobuler, K; Moseley, RH, 1985) |
"It suggests that this rare and highly malignant lymphoma should be considered in the differential diagnosis of interstitial lung disease, and shows the value of open lung biopsy in unexplained interstitial lung disease." | 1.27 | Angiotropic large cell lymphoma presenting as interstitial lung disease. ( Blaisse, M; Gerritzen, FM; Spaander, PJ; Tan, TB, 1988) |
"We describe a patient with ulcerative colitis and extracolonic manifestations in whom diffuse interstitial pulmonary disease developed that was responsive to glucocorticoid therapy one year after total proctocolectomy." | 1.27 | Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease. A trial of N = 1. ( Balestra, DJ; Balestra, ST; Wasson, JH, 1988) |
"Two infants with AIDS who presented with interstitial pneumonitis, failure to thrive, lymphadenopathy, and hypergammaglobulinemia have been studied." | 1.27 | The pathology and treatment of interstitial pneumonitis in two infants with AIDS. ( Conley, ME; Hoxie, JA; Kornstein, MJ; Pietra, GG, 1986) |
"Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown etiology characterized by inflammation of the lower respiratory tract and injury and fibrosis of the lung parenchyma." | 1.27 | Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis. ( Cantin, A; Crystal, RG; Keogh, B; O'Donnell, K, 1987) |
"However, a rare primary malignant lymphoma of the trachea developed and presented with steroid refractory, upper airways obstruction." | 1.27 | Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis. ( Barland, P; Becker, N; Kamholz, S; Rakoff, S; Rosen, N; Sher, A, 1987) |
"A 48-year-old man with systemic lupus erythematosus (SLE) developed disseminated intravascular coagulation (DIC) with clinical bleeding." | 1.27 | Disseminated intravascular coagulation in lupus erythematosus responding to prednisone therapy. ( Riddell, SR; Shojania, AM, 1986) |
"Interstitial pulmonary fibrosis is described in a 26-year-old woman with malignant lymphoma after prolonged intake of cyclophosphamide." | 1.27 | Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. ( Abdel Karim, FW; Allam, C; Ayash, RE; Salem, PA, 1983) |
"Patients with idiopathic pulmonary fibrosis (IPF) are often cigarette smokers and are often being treated with corticosteroids at the time of bronchoalveolar lavage." | 1.27 | Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis. ( Cherniack, RM; Christopher, KL; King, TE; Schwarz, MI; Stanford, RE; Waldron, JA; Watters, LC; Willcox, ML, 1986) |
"The prevalence of spontaneous pneumothorax was studied in 82 patients with cryptogenic fibrosing alveolitis." | 1.27 | Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. ( Gómez de Almeida, R; Letang, E; Montserrat, J; Picado, C; Sánchez-Lloret, J; Xaubet, A, 1985) |
"Five of the six patients had severe bronchial asthma." | 1.26 | Aseptic necrosis of the femoral head in corticosteroid-treated pulmonary disease. ( Klaustermeyer, WB; Richards, JM; Santiago, SM, 1980) |
" The development of interstitial pneumopathy after this low bleomycin dosage may have been favored by a previous thorax irradiation 22 years earler for round cell sarcoma." | 1.26 | [Interstial pneumopathy after low dose bleomycin therapy]. ( Frey, F; Marone, C; Zimmermann, A, 1977) |
"Five stages of allergic bronchopulmonary aspergillosis were identified in 40 patients studied for several years." | 1.26 | Allergic bronchopulmonary aspergillosis: staging as an aid to management. ( Greenberger, PA; Patterson, R; Radin, RC; Roberts, M, 1982) |
"A case of interstitial pulmonary fibrosis secondary to bischloronitrosourea (BCNU) in a 49-year-old man with carcinoma of the pancreas is reported." | 1.26 | Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy. ( Dalton, JF; Hastedt, R; Marshall, D; Raymond, LW; Richter, JE, 1979) |
"Pulmonary fibrosis was diagnosed clinically and by lung biopsy." | 1.26 | Chronic obstructive pulmonary disease following idiopathic pulmonary fibrosis. ( Hershfield, ES; McCarthy, DS; Ostrow, DN, 1980) |
"A patient with nodular histiocytic lymphoma was treated with bleomycin; she later developed interstitial pneumonitis documented by lung biopsy." | 1.25 | Reversible interstitial pneumonitis associated with low dose bleomycin. ( Kardinal, CG; O'Neill, TJ; Tierney, LM, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 169 (63.30) | 18.7374 |
1990's | 50 (18.73) | 18.2507 |
2000's | 25 (9.36) | 29.6817 |
2010's | 20 (7.49) | 24.3611 |
2020's | 3 (1.12) | 2.80 |
Authors | Studies |
---|---|
Borie, R | 1 |
Debray, MP | 1 |
Guedon, AF | 1 |
Mekinian, A | 1 |
Terriou, L | 1 |
Lacombe, V | 1 |
Lazaro, E | 1 |
Meyer, A | 1 |
Mathian, A | 1 |
Ardois, S | 1 |
Vial, G | 1 |
Moulinet, T | 1 |
Terrier, B | 1 |
Jamilloux, Y | 1 |
Heiblig, M | 1 |
Bouaziz, JD | 1 |
Zakine, E | 1 |
Outh, R | 1 |
Groslerons, S | 1 |
Bigot, A | 1 |
Flamarion, E | 1 |
Kostine, M | 1 |
Henneton, P | 1 |
Humbert, S | 1 |
Constantin, A | 1 |
Samson, M | 1 |
Bertrand, NM | 1 |
Biscay, P | 1 |
Dieval, C | 1 |
Lobbes, H | 1 |
Jeannel, J | 1 |
Servettaz, A | 1 |
Adelaide, L | 1 |
Graveleau, J | 1 |
de Sainte-Marie, B | 1 |
Galland, J | 1 |
Guillotin, V | 1 |
Duroyon, E | 1 |
Templé, M | 1 |
Bourguiba, R | 1 |
Georgin Lavialle, S | 1 |
Kosmider, O | 1 |
Audemard-Verger, A | 1 |
Liu, L | 1 |
He, L | 1 |
Wei, W | 1 |
Zhou, M | 1 |
He, B | 1 |
He, J | 1 |
Dameron, M | 1 |
Horowitz, M | 1 |
Gupta, N | 1 |
Abi Hatem, N | 1 |
Cohen, L | 1 |
Guarner, J | 1 |
Hunt, WR | 1 |
Gupta, R | 1 |
Gow, PJ | 1 |
Xu, JF | 1 |
Shen, L | 1 |
Zhang, Y | 2 |
Zhang, P | 1 |
Qu, JM | 1 |
Li, HP | 1 |
Li, J | 1 |
Lin, XY | 1 |
Li, JT | 1 |
Li, XY | 1 |
Liu, YQ | 1 |
Jing, M | 1 |
Sun, SB | 1 |
Su, Y | 1 |
Liu, GW | 1 |
Zhang, X | 1 |
Guo, X | 1 |
Pan, J | 1 |
Ryerson, CJ | 2 |
Olsen, SR | 1 |
Carlsten, C | 1 |
Donagh, C | 1 |
Bilawich, AM | 1 |
Field, SK | 1 |
Churg, A | 2 |
Cui, W | 1 |
Li, L | 1 |
Li, D | 1 |
Mo, X | 1 |
Zhou, W | 1 |
Zhang, Z | 1 |
Xu, L | 1 |
Zhao, P | 1 |
Qi, L | 1 |
Li, P | 1 |
Gao, J | 1 |
Cummings, KJ | 1 |
Kreiss, K | 1 |
Roggli, VL | 1 |
Reiss, S | 1 |
Sultan, D | 1 |
Cros, D | 1 |
Gonzalez, RG | 1 |
Mark, EJ | 1 |
Guilleminault, L | 1 |
Carré, P | 1 |
Diot, P | 1 |
Ketata, W | 1 |
Msaad, S | 1 |
Gharsalli, H | 1 |
Kammoun, K | 1 |
Abid, T | 1 |
Mrabet, S | 1 |
Makni, S | 1 |
Boudawara, T | 1 |
Ayoub, A | 1 |
Spagnolo, P | 1 |
Del Giovane, C | 1 |
Luppi, F | 1 |
Cerri, S | 1 |
Balduzzi, S | 1 |
Walters, EH | 2 |
D'Amico, R | 1 |
Richeldi, L | 3 |
Shaker, OG | 1 |
Sourour, DA | 1 |
Xu, H | 1 |
Li, S | 1 |
Lin, Y | 1 |
Liu, R | 1 |
Gu, Y | 1 |
Liao, D | 1 |
Moritake, H | 1 |
Yamada, A | 1 |
Kimoto, Y | 1 |
Sawa, D | 1 |
Shimonodan, H | 1 |
Nunoi, H | 1 |
Child, N | 1 |
O'Carroll, M | 1 |
Berkahn, L | 1 |
Guimarães, C | 1 |
Sanches, I | 1 |
Ferreira, C | 1 |
Raghu, G | 3 |
Anstrom, KJ | 1 |
King, TE | 5 |
Lasky, JA | 1 |
Martinez, FJ | 2 |
Behr, J | 2 |
Izumi, S | 1 |
Iikura, M | 1 |
Hirano, S | 1 |
Uruga, H | 1 |
Hanada, S | 1 |
Kishi, K | 1 |
Fang, X | 1 |
Zhu, Y | 1 |
Hu, X | 1 |
Liu, Y | 1 |
Nagao, T | 1 |
Nagai, S | 1 |
Hiramoto, Y | 1 |
Hamada, K | 1 |
Shigematsu, M | 1 |
Hayashi, M | 1 |
Izumi, T | 1 |
Mishima, M | 1 |
High, WA | 1 |
Cohen, JB | 1 |
Murphy, BA | 1 |
Costner, MI | 1 |
Davies, HR | 1 |
BICKERMAN, HA | 1 |
BECK, GJ | 1 |
BARACH, AL | 1 |
HOFF, HR | 1 |
HERBERT, FA | 1 |
NAHMIAS, BB | 1 |
GAENSLER, EA | 1 |
MACMAHON, HE | 1 |
OPPENHEIMER, EH | 1 |
QUE, GS | 1 |
MANDEMA, E | 1 |
MICHEL, RD | 1 |
MORRIS, JF | 1 |
JERRY, LM | 1 |
RITCHIE, AC | 1 |
SHERIDAN, LA | 1 |
HARRISON, EG | 2 |
DIVERTIE, MB | 2 |
SILTZBACH, LE | 1 |
DAUM, S | 1 |
NIKODYMOVA, L | 1 |
STIKSA, J | 1 |
VOKAC, Z | 1 |
VAVROVA, V | 1 |
HLOUSKOVA, Z | 1 |
BERGONZI, F | 1 |
NICOLINI, A | 1 |
PALMINIELLO, A | 1 |
DE PENNA, HA | 1 |
MANISSADJIAN, A | 1 |
RAMOS, JL | 1 |
DE PAULA, EA | 1 |
LION, MF | 1 |
MONTENEGRO, MR | 1 |
Gloro, R | 1 |
Ollivier-Hourmand, I | 1 |
Morin-Fatome, A | 1 |
Rousselot, P | 1 |
Le Moel, G | 1 |
Dao, T | 1 |
Demedts, M | 1 |
Buhl, R | 1 |
Costabel, U | 2 |
Dekhuijzen, R | 1 |
Jansen, HM | 1 |
MacNee, W | 1 |
Thomeer, M | 1 |
Wallaert, B | 3 |
Laurent, F | 1 |
Nicholson, AG | 1 |
Verbeken, EK | 1 |
Verschakelen, J | 1 |
Flower, CD | 1 |
Capron, F | 1 |
Petruzzelli, S | 1 |
De Vuyst, P | 1 |
van den Bosch, JM | 1 |
Rodriguez-Becerra, E | 1 |
Corvasce, G | 1 |
Lankhorst, I | 1 |
Sardina, M | 1 |
Montanari, M | 1 |
Hunninghake, GW | 3 |
Yao, HW | 1 |
Zhu, JP | 1 |
Zhao, MH | 1 |
Lu, Y | 1 |
Ríos, G | 1 |
Nathan, SD | 1 |
Walter, N | 1 |
Collard, HR | 1 |
Dury, S | 1 |
Zhang, HQ | 2 |
Yau, YF | 2 |
Szeto, KY | 1 |
Chan, WT | 1 |
Wong, J | 1 |
Li, M | 2 |
Bennett, L | 1 |
Crouse, R | 1 |
Feldstein, D | 1 |
Cambursano, H | 1 |
Cazaux, A | 1 |
Langer, M | 1 |
Paramio, L | 1 |
Sarquis, G | 1 |
Zaya, A | 1 |
Sambuelli, R | 1 |
Wong, MS | 1 |
Man, OY | 1 |
He, YY | 1 |
Chan, N | 1 |
Snavely, NR | 1 |
Sonabend, M | 1 |
Rosen, T | 1 |
Yackel, DB | 1 |
Kempers, RD | 1 |
McConahey, WM | 1 |
Goldberg, NM | 1 |
Mostyn, EM | 1 |
Chodkowska, S | 1 |
Rowińska, E | 1 |
Krakówka, P | 3 |
Matek, W | 1 |
Rösch, W | 1 |
Becker, V | 1 |
Herrmann, R | 1 |
McKee, AL | 1 |
Rajapaksa, A | 1 |
Kalish, PE | 1 |
Pitchumoni, CS | 1 |
DiFilippo, NM | 1 |
Brown, LD | 1 |
Reimer, RR | 1 |
Ahmad, M | 1 |
Hewlett, JS | 1 |
Shinkai, T | 1 |
Saijo, N | 1 |
Tominaga, K | 1 |
Eguchi, K | 1 |
Shimizu, E | 1 |
Shibuya, M | 1 |
Shimabukuro, Z | 1 |
Koketsu, H | 1 |
Nakajima, T | 1 |
Niitani, H | 1 |
Woods, WG | 1 |
Nesbit, ME | 1 |
Ramsay, NK | 1 |
Krivit, W | 1 |
Kim, TH | 1 |
Goldman, A | 1 |
McGlave, PB | 1 |
Kersey, JH | 1 |
Bateman, ED | 2 |
Turner-Warwick, M | 5 |
Haslam, PL | 3 |
Adelmann-Grill, BC | 1 |
Dickey, BF | 1 |
Myers, AR | 1 |
Boven, E | 1 |
Pinedo, HM | 1 |
Lacronique, JG | 1 |
Rennard, SI | 2 |
Bitterman, PB | 1 |
Ozaki, T | 1 |
Crystal, RG | 3 |
Sánchez Posleman, CM | 1 |
Tébar Gil, R | 1 |
Domingo Jiménez, R | 1 |
Gómez Ortigosa, A | 1 |
García de León González, R | 1 |
Pastor Quirante, F | 1 |
González-Moro Prats, L | 1 |
Manresa, F | 1 |
Garau, J | 1 |
Gausí, C | 1 |
Brandstetter, RD | 1 |
Reddy, GN | 1 |
Bhalla, A | 1 |
Fulco, RR | 1 |
Wollmer, P | 1 |
Rhodes, CG | 1 |
Hughes, JM | 1 |
Louw, SJ | 1 |
Benatar, SR | 1 |
Wasicek, CA | 1 |
Reichlin, M | 1 |
Montes, M | 2 |
Teirstein, AS | 1 |
Kleinerman, J | 1 |
Zaher, C | 1 |
Hamer, A | 1 |
Peter, T | 1 |
Mandel, W | 1 |
Abdel Karim, FW | 1 |
Ayash, RE | 1 |
Allam, C | 1 |
Salem, PA | 1 |
Keogh, BA | 1 |
Bernardo, J | 1 |
Line, BR | 1 |
Price, DL | 1 |
Gelb, AF | 1 |
Dreisen, RB | 1 |
Epstein, JD | 1 |
Silverthorne, JD | 1 |
Bickel, Y | 1 |
Fields, M | 1 |
Border, WA | 1 |
Taylor, CR | 1 |
Verhamme, M | 1 |
Wynants, P | 1 |
Van de Woestijne, KP | 1 |
Lauweryns, J | 1 |
Kohler, PF | 1 |
Cook, RD | 1 |
Brown, WR | 1 |
Manguso, RL | 1 |
Hainer, BL | 1 |
White, AA | 1 |
Strumeliev, S | 1 |
Patterson, R | 1 |
Greenberger, PA | 1 |
Radin, RC | 1 |
Roberts, M | 1 |
Blaim, A | 1 |
Mercik, W | 1 |
Kulesza, B | 1 |
Gupta, S | 1 |
Nehru, R | 1 |
Izdebska-Makosa, Z | 2 |
Radwan, L | 1 |
Grebska, E | 1 |
Lesiak, B | 1 |
Rubín, A | 1 |
Krepela, K | 1 |
Janousková, A | 2 |
Biganovská, V | 1 |
Shephard, EG | 1 |
Joubert, JR | 2 |
Finkelstein, MC | 1 |
Kühn, SH | 1 |
McCarthy, DS | 1 |
Ostrow, DN | 1 |
Hershfield, ES | 1 |
Turton, CW | 2 |
Heard, B | 1 |
Lukoszek, A | 2 |
Collins, JV | 2 |
Salsbury, AJ | 2 |
Goucher, G | 1 |
Rowland, V | 1 |
Hawkins, J | 1 |
Dewar, A | 1 |
Richards, JM | 1 |
Santiago, SM | 1 |
Klaustermeyer, WB | 1 |
Burrows, B | 1 |
Johnson, A | 1 |
Niitsu, N | 1 |
Umeda, M | 1 |
Kozielski, J | 1 |
Rauer, R | 1 |
Ziora, D | 1 |
Spychałowicz, W | 1 |
Okubo, Y | 1 |
Nakazawa, K | 1 |
van Oortegem, K | 1 |
Marquette, CH | 1 |
Ramon, P | 1 |
Perez, T | 1 |
Lafitte, JJ | 1 |
Tonnel, AB | 1 |
Nicod, LP | 1 |
Steen, VD | 1 |
Lanz, JK | 1 |
Conte, C | 1 |
Owens, GR | 1 |
Medsger, TA | 1 |
Agustí, C | 1 |
Xaubet, A | 2 |
Agustí, AG | 1 |
Roca, J | 1 |
Ramirez, J | 1 |
Rodriguez-Roisin, R | 1 |
Labrune, S | 1 |
Chinet, T | 1 |
Collignon, MA | 1 |
Barritault, L | 1 |
Huchon, GJ | 1 |
DeRemee, RA | 5 |
Mazer, BD | 1 |
Eigen, H | 1 |
Gelfand, EW | 1 |
Brugman, SM | 1 |
Silver, RM | 1 |
Warrick, JH | 1 |
Kinsella, MB | 1 |
Staudt, LS | 1 |
Baumann, MH | 1 |
Strange, C | 1 |
Peters, SG | 2 |
McDougall, JC | 1 |
Douglas, WW | 4 |
Coles, DT | 1 |
Dayton, CS | 1 |
Schwartz, DA | 1 |
Helmers, RA | 1 |
Pueringer, RJ | 1 |
Gilbert, SR | 1 |
Merchant, RK | 1 |
Pérez de Llano, LA | 1 |
Lancho, A | 1 |
Soilán del Cerro, JL | 1 |
López-Róses, L | 1 |
van Krugten, M | 1 |
Cobben, NA | 1 |
Lamers, RJ | 1 |
van Dieijen-Visser, MP | 1 |
Wagenaar, SS | 1 |
Wouters, EF | 1 |
Drent, M | 1 |
Poloński, L | 2 |
Krzywiecki, A | 2 |
Polońska, A | 2 |
Tendera, M | 2 |
Cwiertka, P | 1 |
Oklek, K | 2 |
Wodniecki, J | 2 |
Kuśnierz, B | 1 |
Uthman, I | 1 |
Vázquez-Abad, D | 1 |
Senécal, JL | 1 |
Shane, E | 1 |
Silverberg, SJ | 1 |
Donovan, D | 1 |
Papadopoulos, A | 1 |
Staron, RB | 1 |
Addesso, V | 1 |
Jorgesen, B | 1 |
McGregor, C | 1 |
Schulman, L | 1 |
Ryu, JH | 4 |
Bjoraker, JA | 2 |
Schroeder, DR | 4 |
Myers, JL | 2 |
Tazelaar, HD | 2 |
Swensen, SJ | 2 |
Scanlon, PD | 1 |
Sharma, OP | 1 |
Edwin, MK | 1 |
Offord, KP | 2 |
Renzoni, E | 1 |
Rottoli, P | 1 |
Coviello, G | 1 |
Perari, MG | 1 |
Galeazzi, M | 1 |
Vagliasindi, M | 1 |
Chap, L | 1 |
Shpiner, R | 1 |
Levine, M | 1 |
Norton, L | 1 |
Lill, M | 1 |
Glaspy, J | 1 |
Nakamura, Y | 1 |
Kohzaki, S | 1 |
Suyama, N | 1 |
Yamaguchi, T | 1 |
Kohno, S | 1 |
Hayashi, K | 1 |
Donaldson, MT | 1 |
Beech, J | 1 |
Ennulat, D | 1 |
Hamir, AN | 1 |
Gay, SE | 1 |
Kazerooni, EA | 1 |
Toews, GB | 1 |
Lynch, JP | 1 |
Gross, BH | 1 |
Cascade, PN | 1 |
Spizarny, DL | 1 |
Flint, A | 1 |
Schork, MA | 1 |
Whyte, RI | 1 |
Popovich, J | 1 |
Hyzy, R | 1 |
Fireman, E | 1 |
Vardinon, N | 1 |
Burke, M | 1 |
Spizer, S | 1 |
Levin, S | 1 |
Endler, A | 1 |
Stav, D | 1 |
Topilsky, M | 2 |
Mann, A | 1 |
Schwarz, Y | 1 |
Kivity, S | 1 |
Greif, J | 1 |
Franquet, T | 1 |
Gimenez, A | 1 |
Alegret, X | 1 |
Rodriguez-Arias, JM | 1 |
Caron, GM | 1 |
Selman, M | 1 |
Carrillo, G | 1 |
Salas, J | 1 |
Padilla, RP | 1 |
Pérez-Chavira, R | 1 |
Sansores, R | 1 |
Chapela, R | 1 |
Becker-Merok, A | 1 |
Nossent, JC | 1 |
Ritland, N | 1 |
Lode, H | 2 |
Erbes, R | 2 |
Raffenberg, M | 1 |
Ciurea-Löchel, A | 1 |
Ciurea, A | 1 |
Stey, C | 1 |
Pestalozzi, B | 1 |
O'Neill, TJ | 1 |
Kardinal, CG | 1 |
Tierney, LM | 1 |
Frey, F | 1 |
Marone, C | 1 |
Zimmermann, A | 1 |
Brown, WG | 1 |
Hasan, FM | 1 |
Barbee, RA | 1 |
Matthay, RA | 1 |
Schwarz, MI | 4 |
Petty, TL | 1 |
Stanford, RE | 3 |
Gupta, RC | 1 |
Sahn, SA | 1 |
Steigerwald, JC | 1 |
Dalquen, P | 1 |
Elke, M | 1 |
Füllemann, HG | 1 |
Matthys, H | 3 |
Sokolowski, JW | 1 |
Harrer, WV | 1 |
Gross, NJ | 1 |
Taetle, R | 1 |
Dickman, PS | 1 |
Feldman, PS | 1 |
Thomas, P | 1 |
Richter, JE | 1 |
Hastedt, R | 1 |
Dalton, JF | 1 |
Marshall, D | 1 |
Raymond, LW | 1 |
Meier-Sydow, J | 2 |
Rust, M | 1 |
Kronenberger, H | 1 |
Thiel, C | 1 |
Amthor, M | 1 |
Riemann, H | 1 |
Alarcón-Segovia, D | 1 |
Uribe-Uribe, O | 1 |
Meuret, G | 1 |
Fueter, R | 1 |
Gloor, F | 1 |
Orwoll, ES | 1 |
Kiessling, PJ | 1 |
Patterson, JR | 1 |
Winterbauer, RH | 3 |
Hammar, SP | 2 |
Hallman, KO | 1 |
Hays, JE | 1 |
Pardee, NE | 2 |
Morgan, EH | 1 |
Allen, JD | 1 |
Moores, KD | 1 |
Bush, W | 1 |
Walker, JH | 1 |
Haluszka, J | 1 |
Rudnik, J | 1 |
Majewska-Zalewska, H | 1 |
Kurzawa, R | 1 |
Flubacher, P | 1 |
Meier, V | 1 |
Obrecht, JP | 1 |
Hartmann, D | 1 |
Vlagopoulos, B | 1 |
Chung, HT | 1 |
Fitzmaurice, FM | 1 |
Campbell, JC | 1 |
Villacorte, GV | 1 |
Tucker, AS | 1 |
Newman, AJ | 1 |
Alvorado, C | 1 |
Patel, AR | 1 |
Shah, PC | 1 |
Rhee, HL | 1 |
Sassoon, H | 1 |
Rao, KP | 1 |
Goldman, AL | 1 |
Enquist, R | 1 |
Park, S | 2 |
Nyhan, WL | 1 |
Marinkovich, VA | 1 |
Hill, A | 1 |
Weese, WC | 1 |
Levine, BW | 1 |
Kazemi, H | 1 |
Binette, JP | 1 |
Baughman, RP | 1 |
Lower, EE | 1 |
Lebbé, C | 1 |
Moulonguet-Michau, I | 1 |
Perrin, P | 1 |
Blanc, F | 1 |
Frija, J | 1 |
Civatte, J | 1 |
Ratjen, FA | 1 |
Schoenfeld, B | 1 |
Wiesemann, HG | 1 |
Riedler, J | 1 |
Golser, A | 1 |
Huttegger, I | 1 |
Pohl, WR | 1 |
Conlan, MG | 1 |
Thompson, AB | 1 |
Ertl, RF | 1 |
Romberger, DJ | 1 |
Mosher, DF | 1 |
Hürter, T | 2 |
Rumpelt, HJ | 2 |
Ferlinz, R | 1 |
Weinblatt, ME | 1 |
Weissman, BN | 1 |
Holdsworth, DE | 1 |
Fraser, PA | 1 |
Maier, AL | 1 |
Falchuk, KR | 1 |
Coblyn, JS | 1 |
Dubaniewicz, A | 1 |
Kuziemski, W | 1 |
Wybieralska, M | 1 |
Maluje, V | 1 |
Alvarado, A | 1 |
Guzmán, L | 1 |
Komiya, I | 1 |
Tanoue, K | 1 |
Kakinuma, K | 1 |
Kaneda, M | 1 |
Shinohara, T | 1 |
Kuriya, S | 1 |
Nomura, T | 1 |
Saito, Y | 1 |
Depaso, WJ | 1 |
Cain, K | 1 |
Wetzel, CE | 1 |
Dreis, DF | 1 |
Hutchinson, J | 1 |
Flammang d'Ortho, MP | 1 |
Cadranel, J | 1 |
Milleron, B | 1 |
Zalcman, G | 1 |
Arvin-Berod, C | 1 |
Terrioux, P | 1 |
Akoun, G | 1 |
Moolman, JA | 1 |
Bardin, PG | 1 |
Rossouw, DJ | 1 |
Gilroy, RJ | 1 |
Teague, MW | 1 |
Loyd, JE | 1 |
Jensen, BV | 1 |
Carlsen, NL | 1 |
Nissen, NI | 1 |
Vuong, TK | 1 |
Laaban, JP | 1 |
De Gennes, C | 1 |
Rochemaure, J | 1 |
Schlegel, J | 1 |
Lorenz, J | 1 |
Bechard, DE | 1 |
Fairman, RP | 1 |
DeBlois, GG | 1 |
Via, CT | 1 |
Zachariae, H | 1 |
Thestrup-Pedersen, K | 1 |
Glenn, LD | 1 |
Armitage, JO | 1 |
Goldsmith, JC | 1 |
Sorensen, S | 1 |
Howe, D | 1 |
Weisenberger, DD | 1 |
Usuba, Y | 1 |
Aiba, S | 1 |
Hashimoto, K | 1 |
Tanita, Y | 1 |
Sakai, K | 1 |
van der Schee, AC | 1 |
Dinkla, BA | 1 |
Festen, JJ | 1 |
al-Janadi, M | 1 |
Smith, CD | 1 |
Karsh, J | 1 |
Atkinson, K | 1 |
Bryant, D | 1 |
Delprado, W | 1 |
Biggs, J | 1 |
Raschko, JW | 1 |
Cottler-Fox, M | 1 |
Abbondanzo, SL | 1 |
Torrisi, JR | 1 |
Spitzer, TR | 1 |
Deeg, HJ | 1 |
Guerry-Force, ML | 1 |
Müller, NL | 2 |
Paré, PD | 1 |
Donevan, RE | 1 |
Grymalowski, MR | 1 |
Pitman, RE | 1 |
Djawari, D | 1 |
Schwanghart, F | 1 |
Karpel, JP | 1 |
Norin, AJ | 1 |
Averbuch, M | 1 |
Halpern, Z | 1 |
Hallak, A | 1 |
Levo, Y | 1 |
Moseley, RH | 1 |
Barwick, KW | 1 |
Dobuler, K | 1 |
DeLuca, VA | 1 |
Bartter, T | 1 |
Irwin, RS | 1 |
Nash, G | 1 |
Balikian, JP | 1 |
Hollingsworth, HH | 1 |
Smith, CM | 1 |
Moser, KM | 1 |
Gupta, AK | 1 |
Davies, GM | 1 |
Haberman, HF | 1 |
Lipton, JH | 1 |
Russell, JA | 1 |
Burgess, KR | 1 |
Hwang, WS | 1 |
Grunnet, ML | 1 |
Abeles, M | 1 |
Hofbauer, H | 1 |
Tan, TB | 1 |
Spaander, PJ | 1 |
Blaisse, M | 1 |
Gerritzen, FM | 1 |
Hedgpeth, MT | 1 |
Boulware, DW | 1 |
Gruhn, WB | 1 |
Diaz-Buxo, JA | 1 |
Vedal, S | 1 |
Welsh, EV | 1 |
Miller, RR | 1 |
Robinson, PC | 1 |
Watters, LC | 3 |
Mason, RJ | 1 |
Popa, V | 1 |
Balestra, DJ | 1 |
Balestra, ST | 1 |
Wasson, JH | 1 |
Kornstein, MJ | 1 |
Pietra, GG | 1 |
Hoxie, JA | 1 |
Conley, ME | 1 |
O'Donnell, K | 1 |
Keogh, B | 1 |
Cantin, A | 1 |
Kamholz, S | 1 |
Sher, A | 1 |
Barland, P | 1 |
Rosen, N | 1 |
Rakoff, S | 1 |
Becker, N | 1 |
Parlevliet, KJ | 1 |
Bronsveld, W | 1 |
Demeter, SL | 1 |
Bott, SJ | 1 |
Stewart, FM | 1 |
Prince-Fiocco, MA | 1 |
Riddell, SR | 1 |
Shojania, AM | 1 |
Cherniack, RM | 2 |
Waldron, JA | 2 |
Dunn, TL | 1 |
Schmitz-Schumann, M | 1 |
Guzman, J | 1 |
Stierle, H | 1 |
Reinbold, WD | 1 |
Willcox, ML | 1 |
Christopher, KL | 1 |
Leahy, F | 1 |
Pasterkamp, H | 1 |
Tal, A | 1 |
Hatron, PY | 1 |
Fourrier, JL | 1 |
Fournier, E | 1 |
Gosselin, B | 1 |
Devulder, B | 1 |
Picado, C | 1 |
Gómez de Almeida, R | 1 |
Montserrat, J | 1 |
Letang, E | 1 |
Sánchez-Lloret, J | 1 |
Tablan, OC | 1 |
Reyes, MP | 1 |
Hugh-Jones, P | 1 |
Macarthur, AM | 1 |
Cullum, PA | 1 |
Mason, SA | 1 |
Crosbie, WA | 1 |
Hutchison, DC | 1 |
Winterton, MC | 1 |
Smith, AP | 1 |
Mason, B | 1 |
Smith, LA | 1 |
Joseph, RR | 1 |
Tourtellotte, CD | 1 |
Barry, WE | 1 |
Smalley, RV | 1 |
Durant, JR | 1 |
Akhtar, M | 1 |
Young, I | 1 |
Riggins, RC | 1 |
Griesman, FA | 1 |
Bauermeister, DE | 1 |
Nagaya, H | 1 |
Elmore, M | 1 |
Ford, CD | 1 |
Shurin, PA | 1 |
Block, AJ | 1 |
Green, GI | 1 |
Levin, RL | 1 |
Pierce, LE | 1 |
Witorsch, P | 1 |
Duncan, PE | 1 |
Griffin, JP | 1 |
Garcia, A | 1 |
Kaplan, SB | 1 |
Zubler, RH | 1 |
Kapanci, Y | 2 |
Miescher, PA | 1 |
Poole-Wilson, PA | 1 |
Carre, JC | 1 |
Dufranc, P | 1 |
Moreau, G | 1 |
Poon, MC | 1 |
Epstein, SW | 1 |
Sepp, H | 1 |
Dierkesmann, R | 1 |
Cegla, UH | 1 |
Kroidl, R | 1 |
Nicolaescu, V | 1 |
Leahu, S | 1 |
Teculescu, D | 1 |
Racoveanu, C | 1 |
Webb, DR | 1 |
Currie, GD | 1 |
Rhodes, ML | 1 |
Colp, CR | 1 |
Riker, J | 1 |
Williams, MH | 1 |
Howatt, WF | 1 |
Heidelberger, KP | 1 |
LeGlovan, DP | 1 |
Schnitzer, B | 1 |
Schlehe, H | 1 |
Konietzko, N | 1 |
Altenstetter, F | 1 |
Tofte, T | 1 |
Grundmann, E | 1 |
Fritzsche, R | 1 |
Frazier, AR | 1 |
Miller, RD | 1 |
Reich, NE | 1 |
McCormack, LJ | 1 |
Van Ordstrand, HS | 1 |
Marie, J | 1 |
Hennequet, A | 1 |
Lévêque, B | 1 |
Debauchez, C | 1 |
Desbois, C | 1 |
Watchi, JM | 1 |
Olsen, GN | 1 |
Swenson, EW | 1 |
Benson, MK | 1 |
Hughes, DT | 1 |
Bolens, M | 1 |
Mégevand, A | 1 |
Brown, CH | 1 |
Castleman, B | 1 |
McNeely, BU | 1 |
Stewart, KR | 1 |
Rona, G | 1 |
Lillie, JB | 1 |
Farr, GH | 1 |
Harley, RA | 1 |
Hennigar, GR | 1 |
Gracey, DR | 1 |
Buchta, RM | 1 |
Giammona, ST | 1 |
Rosenow, EC | 1 |
O'Connell, EC | 1 |
Neuhauser, EB | 1 |
Urbach, F | 1 |
Wine, SS | 1 |
Johnson, WC | 1 |
Davies, RE | 1 |
Rautenstrauch, H | 1 |
Thompson, JE | 1 |
David, RB | 1 |
Andersen, HA | 1 |
Stickler, GB | 1 |
Blazek, F | 1 |
Herdegen, L | 1 |
Vondrová, B | 1 |
Howard, EJ | 1 |
Michaud, P | 1 |
Palma, J | 1 |
Riesco, J | 1 |
Raggio, R | 1 |
Rodriguez, J | 1 |
Kennedy, WP | 1 |
Shearman, DJ | 1 |
Delamore, IW | 1 |
Simpson, JD | 1 |
Black, JW | 1 |
Grant, IW | 1 |
Eschenbach, C | 1 |
Dietzsch, HJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Randomized Controlled Trial[NCT05674994] | Phase 3 | 110 participants (Anticipated) | Interventional | 2023-10-26 | Recruiting | ||
Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF[NCT00650091] | Phase 3 | 264 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa[NCT05537220] | Phase 3 | 438 participants (Anticipated) | Interventional | 2023-10-11 | Recruiting | ||
Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial[NCT02460588] | Phase 3 | 120 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
Idiopathic Pulmonary Fibrosis International Group Exploring NAC I Annual Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)[NCT00639496] | Phase 3 | 184 participants (Actual) | Interventional | 2000-03-31 | Completed | ||
A Phase One, Open Label, Multi-Dose Study to Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients With Idiopathic Pulmonary Fibrosis (IPF)[NCT01199887] | Phase 1 | 30 participants (Actual) | Interventional | 2010-09-30 | Completed | ||
[NCT00000596] | Phase 2 | 0 participants | Interventional | 1978-06-30 | Completed | ||
[NCT00005279] | 0 participants | Observational | 1971-06-30 | Completed | |||
Targeted Intervention for Patient Centered Outcome in Patients With Idiopathic Pulmonary Fibrosis[NCT03480451] | 1 participants (Actual) | Interventional | 2017-09-12 | Terminated (stopped due to Study considered futile) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"The following 3 criteria will define acute exacerbations in subjects with acute worsening of their respiratory conditions:~1. Clinical (all of the following required): A) Unexplained worsening of dyspnea or cough within 30 days, triggering unscheduled medical care (e.g., emergency room, clinic, study visit, hospitalization). B) No clinical suspicion or overt evidence of cardiac event, pulmonary embolism, or deep venous thrombosis to explain acute worsening of dyspnea. C) No pneumothorax." (NCT00650091)
Timeframe: Measured at Week 60
Intervention | events (Number) |
---|---|
N-Acetylcysteine | 3 |
Placebo | 3 |
"The time-to-death or a 10% decline in FVC will be defined as the time-to-disease progression.~The 10% decline in FVC from enrollment must be confirmed on 2 consecutive visits no less than 6 weeks apart. For subjects with 2 consecutive visits with a 10% decline in FVC, the time-to-disease progression will be defined as the time interval between enrollment and the initial visit with a 10% FVC decline." (NCT00650091)
Timeframe: Measured at Week 60
Intervention | percentage of participants (Number) |
---|---|
N-Acetylcysteine | 27.1 |
Placebo | 26.5 |
Maintained forced vital capacity response was a binary variable taking on a value of 1 for participants with higher FVC % predicted at week 60 compared to baseline. (NCT00650091)
Timeframe: Measured at Week 60
Intervention | participants (Number) |
---|---|
N-Acetylcysteine | 29 |
Placebo | 35 |
Change from Baseline in Forced Vital Capacity at 60 weeks (units in liters) (NCT00650091)
Timeframe: Measured as the estimated change from baseline to Week 60
Intervention | liters (Mean) |
---|---|
N-Acetylcysteine | -0.18 |
Placebo | -0.19 |
(NCT00650091)
Timeframe: Measured at Week 60
Intervention | events (Number) |
---|---|
N-Acetylcysteine | 6 |
Placebo | 6 |
Change from Baseline in Forced Vital Capacity at 15, 30, 45, and 60 weeks (units in liters) (NCT00650091)
Timeframe: Baseline, 15, 30, 45, 60 week
Intervention | liters (Mean) | |||
---|---|---|---|---|
15 week | 30 week | 45 week | 60 week | |
N-Acetylcysteine | -0.07 | -0.07 | -0.15 | -0.16 |
Placebo | -0.04 | -0.08 | -0.15 | -0.15 |
19 reviews available for prednisone and Alveolitis, Fibrosing
Article | Year |
---|---|
Non-steroid agents for idiopathic pulmonary fibrosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colchicine; Cyclophosphamide; Humans; Immunos | 2010 |
Immunomodulatory agents for idiopathic pulmonary fibrosis.
Topics: Azathioprine; Colchicine; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferon-gamma; Pred | 2003 |
BRONCHIOLAR EMPHYSEMA. A REPORT OF A NECROPSIED CASE OF DIFFUSE BRONCHIOLECTASIS AND REVIEW OF THE LITERATURE.
Topics: Autopsy; Bronchial Diseases; Bronchiectasis; Bronchioles; Dilatation; Emphysema; Humans; Hyperplasia | 1964 |
[PROGRESSIVE DIFFUSE INTERSTITIAL FIBROSIS OF THE LUNGS (HAMMAN-RICH SYNDROME): REPORT OF A CASE IN CHILDHOOD, DIAGNOSED DURING LIFE BY LUNG BIOPSY, WITH A LONG SURVIVAL THROUGH CORTICOSTEROID THERAPY].
Topics: Adrenal Cortex Hormones; Biopsy; Child; Diagnosis; Drug Therapy; Humans; Lung; Prednisone; Pulmonary | 1965 |
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug | 2006 |
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anticoagulants; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Im | 2006 |
[Bronchopulmonary sarcoidosis. Brief review and description of 8 cases].
Topics: Adult; Diagnosis, Differential; Female; Glucocorticoids; Granuloma; Humans; Lymphatic Diseases; Male | 2006 |
[Recent developments in the treatment of chronic myeloid leukemia].
Topics: Adult; Antineoplastic Agents; BCG Vaccine; Busulfan; Drug Therapy, Combination; Female; Hematopoieti | 1980 |
Pulmonary disease in polymyositis/dermatomyositis.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Dermatomyositis; Female; Humans; Immunosuppressive Agents | 1984 |
Nitrofurantoin pulmonary toxicity.
Topics: Acute Disease; Aged; Chronic Disease; Dyspnea; Female; Humans; Middle Aged; Nitrofurantoin; Predniso | 1981 |
[Diffuse fibrosing alveolitis (author's transl)].
Topics: Azathioprine; Humans; Lung; Penicillamine; Prednisone; Pulmonary Fibrosis | 1981 |
Newer drugs in the treatment of idiopathic pulmonary fibrosis.
Topics: Anti-Inflammatory Agents; Colchicine; Cytokines; Humans; Immunosuppressive Agents; Prednisone; Pulmo | 1997 |
Pulmonary effects of radiation therapy.
Topics: Animals; Breast Neoplasms; Diagnosis, Differential; Humans; Lung; Lung Diseases; Lung Neoplasms; Ple | 1977 |
Pulmonary histopathologic changes associated with melphalan therapy.
Topics: Aged; Drug Therapy, Combination; Epithelium; Humans; Lung; Male; Melphalan; Middle Aged; Multiple My | 1978 |
Fibrosing alveolitis.
Topics: Adult; Aged; Humans; Lung; Middle Aged; Prednisone; Prognosis; Pulmonary Alveoli; Pulmonary Fibrosis | 1978 |
[Interstitial pulmonary involvement of polymyositis and dermatomyositis. Apropos of 3 cases. Review of the literature].
Topics: Adult; Antibodies, Antinuclear; Bronchoalveolar Lavage Fluid; Dermatomyositis; Female; Humans; Male; | 1991 |
[A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1989 |
Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporine.
Topics: Adult; Bone Marrow Transplantation; Cyclosporins; Humans; Leukemia, Myeloid, Acute; Male; Postoperat | 1989 |
Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis.
Topics: Adult; Azathioprine; Cyclosporins; Dermatomyositis; Drug Resistance; Female; Humans; Myositis; Predn | 1987 |
16 trials available for prednisone and Alveolitis, Fibrosing
Article | Year |
---|---|
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combinat | 2012 |
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Dru | 2005 |
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Dru | 2005 |
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Dru | 2005 |
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Dru | 2005 |
Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Male; | 1983 |
Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cell Count; Cyclophosphamide; Female; Humans; Immunosuppressive | 1994 |
Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Female; Humans; Male; Middle Aged; Prednisone | 1993 |
[Effects of long term oxygen therapy in patients with idiopathic pulmonary fibrosis. I. Effect on the course of the primary disease and on pulmonary circulation].
Topics: Adult; Anti-Inflammatory Agents; Blood Pressure; Bronchodilator Agents; Expectorants; Female; Follow | 1995 |
[Effects of long term oxygen therapy in patients with idiopathic pulmonary fibrosis. II. Effect of oxygen therapy on function of heart ventricles].
Topics: Adult; Anti-Inflammatory Agents; Echocardiography; Female; Follow-Up Studies; Home Nursing; Humans; | 1995 |
Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C | 1997 |
Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Female; Humans; | 1998 |
Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial.
Topics: Adult; Colchicine; Drug Therapy, Combination; Follow-Up Studies; Humans; Middle Aged; Penicillamine; | 1998 |
[Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Penicillamine; | 1979 |
Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis.
Topics: Cyclophosphamide; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle | 1992 |
Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.
Topics: Aged; Arthritis, Rheumatoid; Biopsy; Drug Administration Schedule; Humans; Liver; Liver Cirrhosis; M | 1992 |
Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.
Topics: Azathioprine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pre | 1991 |
Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Humans; Middle Aged; Prednisone; Pulmonary Fib | 1991 |
[Course and prognosis of idiopathic diffuse pulmonary fibrosis in the light of our studies].
Topics: Adolescent; Adult; Clinical Trials as Topic; Dexamethasone; Female; Humans; Male; Poland; Prednisone | 1968 |
232 other studies available for prednisone and Alveolitis, Fibrosing
Article | Year |
---|---|
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
Topics: Aged; Female; Humans; Lung; Male; Mutation; Prednisone; Pulmonary Fibrosis; Syndrome; Vacuoles | 2023 |
[Unsaturated fatty acid of Actinidia chinesis planch seed oil protects against pulmonary fibrosis by inhibiting collagen synthesis via down-regulating connective tissue growth factor (CTGF) expression in rats].
Topics: Acetates; Actinidia; Animals; Collagen Type I; Connective Tissue Growth Factor; Fatty Acids, Unsatur | 2022 |
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromis | 2021 |
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Graft Rejection; Humans; Immunosu | 2017 |
Inflammatory myopathies--a review of newly diagnosed patients (2004-2008) in the Counties Manukau region.
Topics: Adult; Aged; Antibodies, Antinuclear; Biopsy; Blood Sedimentation; C-Reactive Protein; Creatine Kina | 2013 |
Lung biopsy-proved hypersensitivity pneumonitis without known offending antigen: characteristics and follow-up.
Topics: Adult; Aged; Alveolitis, Extrinsic Allergic; Biopsy; Blood Sedimentation; C-Reactive Protein; Carbon | 2014 |
[Effect of flavonoids from hedysari radix on pulmonary functions of pulmonary fibrosis rat].
Topics: Animals; Bleomycin; Drugs, Chinese Herbal; Fabaceae; Flavonoids; Forced Expiratory Volume; Lung; Lun | 2013 |
Increased levels of tumor necrosis factor-α involved in rituximab-related acute pulmonary fibrosis in diffuse large B-cell lymphoma.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemothera | 2015 |
Fibrosing Bronchiolitis Evolving from Infectious or Inhalational Acute Bronchiolitis. A Reversible Lesion.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; | 2015 |
Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.
Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Dose-Response Relationship, Drug; Drugs, Chinese Herba | 2015 |
Bronchiolitis by Any Other Name: Describing Bronchiolar Disorders from Inhalational Exposures.
Topics: Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Humans; Male; | 2016 |
Reply: Bronchiolitis by Any Other Name: Describing Bronchiolar Disorders from Inhalational Exposures.
Topics: Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cryptogenic Organizing Pneumonia; Humans; Male; | 2016 |
Risk Factors in the Development of Oral Bisphosphonate-induced Osteonecrosis.
Topics: Abscess; Administration, Oral; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw | 2015 |
Case records of the Massachusetts General Hospital. Case 6-2009. A 37-year-old woman with vertigo, facial weakness, and a generalized seizure.
Topics: Adult; Amenorrhea; Anti-Inflammatory Agents; Biopsy; Brain; Brain Diseases; Diagnosis, Differential; | 2009 |
Hypersensitivity pneumonitis associated with temozolomide.
Topics: Alveolitis, Extrinsic Allergic; Biopsy; Brain; Dacarbazine; Dyspnea; Humans; Lung; Lung Diseases, In | 2009 |
[Pulmonary fibrosis as a presentation of Wegener's granulomatosis].
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Diagnos | 2009 |
Effect of leukotriene receptor antagonists on lung fibrosis in rats.
Topics: Acetates; Animals; Bleomycin; Collagen; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combin | 2011 |
[Effectiveness of cultured Cordyceps sinensis combined with glucocorticosteroid on pulmonary fibrosis induced by bleomycin in rats].
Topics: Animals; Bleomycin; Connective Tissue Growth Factor; Cordyceps; Drug Therapy, Combination; Lung; Mal | 2011 |
Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.
Topics: Antimetabolites, Antineoplastic; Biomarkers; Biomarkers, Tumor; Cytarabine; Cytokines; Disease Progr | 2012 |
Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; | 2012 |
Acute fibrinous and organising pneumonia.
Topics: Acute Disease; Biomarkers, Tumor; Biopsy; Bronchoscopy; Cryptogenic Organizing Pneumonia; Diagnosis, | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
[Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Bleomycin; Chemoki | 2002 |
Serial evaluation of high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis in usual interstitial pneumonia.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cohort Studies; Disease Progression; Female; Humans; Lung Dis | 2002 |
Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis.
Topics: Antibodies, Antinuclear; Dermatomyositis; Fatal Outcome; Glucocorticoids; Humans; Immunosuppressive | 2003 |
The use of prednisone (Meticorten) in respiratory disease. II. Pulmonary emphysema and pulmonary fibrosis.
Topics: Emphysema; Fibrosis; Humans; Prednisone; Pulmonary Emphysema; Pulmonary Fibrosis; Respiration Disord | 1955 |
The Hamman-Rich syndrome; review of the literature and report of a case treated with prednisone.
Topics: Humans; Prednisone; Pulmonary Fibrosis | 1958 |
Pathophysiology of interstitial pulmonary fibrosis. Report of 19 cases and follow-up with corticosteroids.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cardiovascular Agents; Dexamethasone; Follow-U | 1962 |
LESIONS IN THE ADRENALS OF AN INFANT FOLLOWING MATERNAL CORTICOSTEROID THERAPY.
Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Glands; Female; Humans; Infant, Newborn; In | 1964 |
A CASE OF IDIOPATHIC RETROPERITONEAL FIBROSIS PRESENTING AS A SYSTEMIC COLLAGEN DISEASE.
Topics: Adolescent; Autoimmune Diseases; Blood Protein Disorders; Blood Transfusion; Chloroquine; Collagen D | 1964 |
ACUTE SILICOSIS.
Topics: Humans; Pathology; Prednisone; Pulmonary Fibrosis; Radiography, Thoracic; Respiratory Function Tests | 1964 |
THE CURRENT STATUS OF IDIOPATHIC PULMONARY FIBROSIS (HAMMAN-RICH SYNDROME).
Topics: Anti-Bacterial Agents; Aspirin; Biopsy; Child; Diagnosis, Differential; Digitalis Glycosides; Diuret | 1964 |
DIFFUSE PULMONARY GRANULOMATOSES AND FIBROSES.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Beryllium; C | 1964 |
[DIFFUSION CAPACTIY OF THE LUNG AND ITS COMPONENTS IN INTERSTITIAL PULMONARY FIBROSIS IN CHILDHOOD].
Topics: Adolescent; Child; Drug Therapy; Humans; Prednisone; Pulmonary Fibrosis; Respiratory Function Tests | 1964 |
[THE HAMMAN-RICH SYNDROME IN CHILDHOOD (OBSERVATION OF A CASE)].
Topics: Humans; Infant; Prednisone; Pulmonary Fibrosis | 1964 |
Interferon gamma-1b for pulmonary fibrosis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Humans; Interferon-gamma; Prednisone; Pulmonary F | 2004 |
[Disseminated strongyloidiasis associated with pulmonary fibrosis and gastrointestinal bleeding].
Topics: Aged; Anthelmintics; Bronchoalveolar Lavage; Bronchoscopy; Gastrointestinal Hemorrhage; Glucocortico | 2004 |
Antioxidant therapy for idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Glu | 2005 |
Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Bleomycin; Body Weigh | 2006 |
Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Arthritis, Rheumatoid; Biopsy; | 2005 |
[Treatment of idiopathic pulmonary fibrosis].
Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Cyclopho | 2006 |
Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis.
Topics: Animals; Bronchoalveolar Lavage Fluid; Carbon Tetrachloride; Collagen; Disease Models, Animal; Drugs | 2007 |
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe?
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combinatio | 2006 |
Chinese medicine formula DSQRL versus glucocorticoids for the treatment of experimental pulmonary fibrosis.
Topics: Animals; Bronchoalveolar Lavage Fluid; Male; Medicine, Chinese Traditional; Prednisone; Pulmonary Fi | 2008 |
Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation.
Topics: Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Face; Humans; Immunosuppression The | 2007 |
Adrenocorticosteroid therapy in pregnancy.
Topics: Adrenal Gland Diseases; Adult; Arthritis, Rheumatoid; Asthma; Birth Weight; Blood Group Incompatibil | 1966 |
Desquamative interstitial pneumonia: a brief review of the literature and a discussion of treatment with oxygen and corticosteroids.
Topics: Adult; Hematocrit; Humans; Male; Oxygen; Polycythemia; Prednisone; Pulmonary Fibrosis; Respiratory F | 1967 |
[A case of complications in the course of sarcoidosis].
Topics: Adult; Aspergillosis; Humans; Lung Diseases; Male; Prednisone; Pulmonary Emphysema; Pulmonary Fibros | 1967 |
[Pathological changes in lungs and liver after therapy of ulcerative colitis].
Topics: Amitriptyline; Chlordiazepoxide; Colitis, Ulcerative; Humans; Jaundice; Male; Middle Aged; Penicilla | 1980 |
Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis.
Topics: Bronchiectasis; Colectomy; Colitis, Ulcerative; Female; Humans; Middle Aged; Prednisone; Pulmonary F | 1983 |
The recurrence of alveolitis in interstitial lung disease.
Topics: Aged; Humans; Male; Prednisone; Pulmonary Fibrosis; Recurrence | 1984 |
Successful treatment of bleomycin lung.
Topics: Adult; Bleomycin; Humans; Male; Middle Aged; Prednisone; Pulmonary Fibrosis | 1980 |
Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Topics: Age Factors; Aged; Antibiotics, Antineoplastic; Bleomycin; Carbazilquinone; Drug Therapy, Combinatio | 1983 |
Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
Topics: Adolescent; Adult; Age Factors; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; | 1983 |
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.
Topics: Adult; Aged; Collagen; Female; Fluorescent Antibody Technique; Humans; Lung; Male; Middle Aged; Pred | 1983 |
Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome.
Topics: Adult; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Prednisone; Pulmonary Fibro | 1983 |
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor.
Topics: Adult; Depression, Chemical; Dexamethasone; Female; Fibronectins; Glucocorticoids; Growth Substances | 1984 |
[Desquamating interstitial pneumonia].
Topics: Biopsy; Child; Female; Humans; Lung; Prednisone; Pulmonary Fibrosis | 1984 |
[Interstitial pneumonitis and amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Humans; Male; Middle Aged; Prednisone; Pulmonary Fi | 1984 |
Idiopathic pulmonary fibrosis presenting as bilateral, ill-defined pulmonary densities.
Topics: Aged; Diagnosis, Differential; Humans; Lung Neoplasms; Male; Prednisone; Pulmonary Fibrosis; Radiogr | 1984 |
Regional extravascular density and fractional blood volume of the lung in interstitial disease.
Topics: Adult; Aged; Blood Volume; Female; Humans; Lung; Lung Volume Measurements; Male; Middle Aged; Predni | 1984 |
Cryptogenic fibrosing alveolitis. Clinical spectrum and treatment.
Topics: Adult; Aged; Blood Cell Count; Female; Humans; Male; Middle Aged; Prednisone; Prognosis; Prospective | 1984 |
Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype.
Topics: Antibody Specificity; Autoantibodies; Electromyography; Humans; Male; Middle Aged; Myositis; Prednis | 1984 |
Diffuse interstitial lung disease.
Topics: Adrenal Cortex Hormones; Humans; Lung Diseases; Prednisone; Pulmonary Fibrosis | 1981 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-1983. A 60-year-old man with rapidly progressive dyspnea.
Topics: Humans; Lung; Male; Middle Aged; Prednisone; Pulmonary Alveolar Proteinosis; Pulmonary Alveoli; Pulm | 1983 |
Low-dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Male; Middle Aged; Pneumonia; Prednisone; Pul | 1983 |
Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report.
Topics: Adult; Cyclophosphamide; Female; Humans; Lymphoma; Prednisone; Pulmonary Fibrosis; Radiography | 1983 |
Immune complexes, gallium lung scans, and bronchoalveolar lavage in idiopathic interstitial pneumonitis-fibrosis.
Topics: Adult; Aged; Antigen-Antibody Complex; Bronchi; Female; Gallium Radioisotopes; Humans; Lung; Male; M | 1983 |
[Lymphoid interstitial pneumonia. Presentation of 2 cases with follow-up].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diag | 1982 |
Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy.
Topics: Adult; Agammaglobulinemia; B-Lymphocytes; Female; Humans; Hyperplasia; Lung; Lymph Nodes; Prednisone | 1982 |
Allergic bronchopulmonary aspergillosis: staging as an aid to management.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspergillosis, Allergic Bronchopulm | 1982 |
[Adrenal cortex function in children after long-term treatment with corticoids].
Topics: Adolescent; Adrenal Cortex; Asthma; Child; Female; Humans; Male; Prednisone; Pulmonary Fibrosis; Tim | 1982 |
Rheumatoid arthritis with extra-articular manifestations.
Topics: Adult; Arthritis, Rheumatoid; Humans; Male; Prednisone; Pulmonary Fibrosis; Spinal Cord Compression | 1982 |
Idiopathic pulmonary fibrosis.
Topics: Biopsy; Female; Humans; Middle Aged; Oxygen Inhalation Therapy; Prednisone; Pulmonary Alveoli; Pulmo | 1981 |
[Long-term observation of patients with pulmonary fibrosis with good treatment results].
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Pulmonary | 1981 |
Diffuse interstitial lung fibrosis from childhood and adolescence to adult life.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Prednisone; Pul | 1981 |
Phagocytosis of liposomes by human alveolar macrophages.
Topics: Cholesterol; Follow-Up Studies; Humans; Immunoglobulin G; Inulin; Liposomes; Macrophages; Phagocytos | 1981 |
Chronic obstructive pulmonary disease following idiopathic pulmonary fibrosis.
Topics: Airway Resistance; Female; Humans; Lung Compliance; Lung Diseases, Obstructive; Middle Aged; Prednis | 1980 |
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.
Topics: Adult; Biopsy; Cell Count; Female; Humans; Lung; Male; Middle Aged; Prednisone; Pulmonary Fibrosis; | 1980 |
Melphalan-induced pulmonary interstitial fibrosis.
Topics: Female; Humans; Melphalan; Middle Aged; Prednisone; Pulmonary Fibrosis | 1980 |
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.
Topics: Adult; Aged; Bronchi; Cyclophosphamide; Eosinophils; Female; Humans; Leukocyte Count; Macrophages; M | 1980 |
Aseptic necrosis of the femoral head in corticosteroid-treated pulmonary disease.
Topics: Adult; Asthma; Female; Femur Head Necrosis; Glucocorticoids; Humans; Male; Methylprednisolone; Middl | 1980 |
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.
Topics: Adrenal Cortex Hormones; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisolone; P | 1980 |
[Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar | 1994 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans | 1994 |
[Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Granulocyt | 1993 |
Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
Topics: Bronchoalveolar Lavage Fluid; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies | 1994 |
[Treatment of idiopathic pulmonary fibrosis].
Topics: Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Lung Dise | 1995 |
Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up.
Topics: Adolescent; Adult; Aged; Bronchoalveolar Lavage Fluid; Exercise Test; Female; Follow-Up Studies; Hum | 1994 |
Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis.
Topics: Aerosols; Epithelium; Forced Expiratory Volume; Humans; Lung; Mucociliary Clearance; Prednisone; Pul | 1994 |
New approaches to the treatment of pulmonary fibrosis.
Topics: Acetylcysteine; Colchicine; Humans; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Terminolog | 1994 |
Remission of interstitial lung disease following therapy of associated ulcerative colitis.
Topics: Adolescent; Biopsy; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Lung; Prednisone | 1993 |
Colchicine in the treatment of pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Bronchoscopy; Colchicine; Cyclophosphamide; Fe | 1993 |
Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies.
Topics: Administration, Oral; Age Factors; Cyclophosphamide; Drug Therapy, Combination; Dyspnea; Female; Fol | 1993 |
Cryptogenic fibrosing alveolitis predating ulcerative colitis.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprin | 1996 |
Serum LDH: a marker of disease activity and its response to therapy in idiopathic pulmonary fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Hu | 1996 |
Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoi | 1996 |
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Bone Density; Cystic Fibrosis; Female; Fractures, S | 1996 |
Colchicine versus prednisone as treatment of usual interstitial pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colchicine; Female; Humans; Lung Diseases, Inters | 1997 |
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Female; Humans; Male; Middle Aged; | 1998 |
Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease.
Topics: Antibodies, Antinuclear; Bronchoalveolar Lavage Fluid; Connective Tissue Diseases; Diagnosis, Differ | 1997 |
Systemic idiopathic fibrosis with inflammatory pulmonary lesions.
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Lung Neoplasms; Male; Prednisone; P | 1997 |
Interstitial pneumonia and pulmonary fibrosis in a horse.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Diagnosis, | 1998 |
Idiopathic pulmonary fibrosis: predicting response to therapy and survival.
Topics: Adult; Aged; Analysis of Variance; Biopsy, Needle; Cyclophosphamide; Female; Forced Expiratory Volum | 1998 |
Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis.
Topics: Bronchoalveolar Lavage Fluid; CD4-CD8 Ratio; Cell Count; Cell Separation; Female; Flow Cytometry; Fo | 1998 |
Mediastinal lymphadenopathy in cryptogenic fibrosing alveolitis: the effect of steroid therapy on the prevalence of nodal enlargement.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Lymphatic Diseases; Male; Mediast | 1998 |
Fibrosing alveolitis predating microscopic polyangiitis.
Topics: Aged; Glomerulonephritis; Humans; Male; Necrosis; Peripheral Nervous System Diseases; Prednisone; Pu | 1999 |
Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival.
Topics: Aged; Colchicine; Female; Glucocorticoids; Humans; Male; Multivariate Analysis; Oxygen Inhalation Th | 2000 |
[Idiopathic pulmonary fibrosis. II. Treatment].
Topics: Adrenal Cortex Hormones; Age Factors; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combinat | 2001 |
[Idiopathic pulmonary fibrosis. III. Case report].
Topics: Age Factors; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Combinati | 2001 |
[Lung infiltrations in Hodgkin lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Hodgkin D | 2001 |
Reversible interstitial pneumonitis associated with low dose bleomycin.
Topics: Abdominal Neoplasms; Bleomycin; Doxorubicin; Female; Humans; Lymphatic Metastasis; Lymphoma, Large B | 1975 |
[Interstial pneumopathy after low dose bleomycin therapy].
Topics: Bleomycin; Female; Hematopoiesis; Humans; Middle Aged; Neoplasm Metastasis; Prednisone; Pulmonary Fi | 1977 |
Reversibility of severe bleomycin-induced pneumonitis.
Topics: Bleomycin; Carcinoma, Squamous Cell; Female; Humans; Lung; Middle Aged; Prednisone; Pulmonary Fibros | 1978 |
Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Cardiomegaly; Female; Humans; Lung Volume Meas | 1975 |
[Pulmonary fibrosis (author's transl)].
Topics: Alcoholism; Diuretics; Humans; Lung; Male; Middle Aged; Penicillins; Prednisone; Pulmonary Fibrosis; | 1978 |
Desquamative interstitial pneumonia (DIP).
Topics: Humans; Prednisone; Pulmonary Fibrosis; Radiography | 1979 |
Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
Topics: Carmustine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prednisone; Pulmonary Fibrosis; Radiogr | 1979 |
Mutilans-like arthropathy in mixed connective tissue disease.
Topics: Adult; Arthritis; Bone Resorption; Female; Fingers; Humans; Mixed Connective Tissue Disease; Prednis | 1979 |
Early stage of fulminant idiopathic pulmonary fibrosis cured by intense combination therapy using cyclophosphamide, vincristine, and prednisone.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Humans; Male; Prednisone; Pulmonary Fibrosis; Vi | 1978 |
Interstitial pneumonia from mitomycin.
Topics: Female; Humans; Male; Middle Aged; Mitomycins; Prednisone; Pulmonary Fibrosis; Radiography | 1978 |
Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Lung; Male; Middle Aged; Pneum | 1978 |
[Effect of encorton therapy on the ventilatory function of children with pulmonary fibrosis].
Topics: Age Factors; Child; Child, Preschool; Humans; Lung; Prednisone; Pulmonary Fibrosis; Respiration | 1977 |
[Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].
Topics: Aged; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Ethinyl Estradiol; Female; Femo | 1977 |
Desquamative interstitial pneumonia associated with granulomatous lymphadenopathy.
Topics: Child; Female; Granuloma; Humans; Lymphatic Diseases; Prednisone; Pulmonary Fibrosis | 1977 |
Pulmonary, pleural and thoracic changes complicating chemotherapy.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Male; Prednisone; Pulmonary F | 1977 |
Cyclophosphamide therapy and interstitial pulmonary fibrosis.
Topics: Adult; Aged; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; | 1976 |
Hyperacute radiation pneumonitis.
Topics: Acute Disease; Adult; Humans; Lung; Lung Neoplasms; Male; Pneumonia; Prednisone; Pulmonary Fibrosis; | 1975 |
Fatal pulmonary involvement in dermatomyositis.
Topics: Anti-Bacterial Agents; Bronchopneumonia; Child; Dermatomyositis; Diagnostic Errors; Duodenal Ulcer; | 1975 |
Hypersensitivity alveolitis.
Topics: Air Conditioning; Air Microbiology; Biopsy; Child; Dyspnea; Environmental Exposure; Female; Humans; | 1975 |
[Proceedings: Round table discussion: Differential diagnosis and therapy of interstitial lung diseases].
Topics: Azathioprine; Biopsy; Diagnosis, Differential; Humans; Lung; Lung Compliance; Penicillamine; Prednis | 1975 |
Interstitial lung disease resistant to corticosteroid therapy. Report of three cases treated with azathioprine or cyclophosphamide.
Topics: Adult; Azathioprine; Cyclophosphamide; Humans; Immunosuppression Therapy; Male; Middle Aged; Prednis | 1975 |
Lymphoid interstitial pneumonia.
Topics: Adult; Biopsy; Eosinophils; Histiocytes; Humans; Lung; Lymph Nodes; Lymphocytes; Male; Plasma Cells; | 1976 |
Steroid-responsive pyoderma gangrenosum with vulvar and pulmonary involvement.
Topics: Female; Humans; Middle Aged; Prednisone; Pulmonary Fibrosis; Pyoderma Gangrenosum; Ulcer; Vulvar Dis | 1992 |
Pulmonary alveolar microlithiasis and lymphocytic interstitial pneumonitis in a ten year old girl.
Topics: Bronchoalveolar Lavage Fluid; Calculi; Child; Female; Humans; Leukocyte Count; Lung Diseases; Lympho | 1992 |
Fibrosing alveolitis in an infant.
Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Hypoxia; Infant; Lung; Oxygen; Prednisone; | 1992 |
Vitronectin in bronchoalveolar lavage fluid is increased in patients with interstitial lung disease.
Topics: Blood Proteins; Bronchoalveolar Lavage Fluid; Female; Glycoproteins; Humans; Male; Middle Aged; Osmo | 1991 |
Fibrosing alveolitis responsive to corticosteroids following Legionnaires' disease pneumonia.
Topics: Humans; Legionnaires' Disease; Lung; Male; Middle Aged; Prednisone; Pulmonary Fibrosis; Radiography | 1992 |
[Interstitial lung disease in Langerhans-cell granulomatosis in a 34-year-old woman].
Topics: Adult; Diabetes Insipidus; Eosinophilic Granuloma; Female; Humans; Mandibular Diseases; Osteolysis; | 1991 |
[Spontaneous fracture of the sacrum in patient with pulmonary fibrosis and steroid treatment].
Topics: Chloroquine; Female; Fractures, Spontaneous; Humans; Middle Aged; Naproxen; Osteoporosis, Postmenopa | 1991 |
Superoxide anion hyperproduction by neutrophils in a case of myelodysplastic syndrome. Association with Sweet's syndrome and interstitial pneumonia.
Topics: Dermatitis; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Myristic Acid; Myristic Acids; Neu | 1991 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1991. An 80-year-old woman with increasing dyspnea and extensive pulmonary opacities while receiving a decreasing prednisone dose for polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Lung; Polymyalgia Rheumatica; Pred | 1991 |
Pulmonary veno-occlusive disease. Fatal progression of pulmonary hypertension despite steroid-induced remission of interstitial pneumonitis.
Topics: Adult; Female; Heart Failure; Humans; Hypertension, Pulmonary; Lung; Prednisone; Pulmonary Fibrosis; | 1991 |
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Femal | 1990 |
[Still's disease in adults with a pulmonary site].
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Prednisone; Pulmonary Fibrosis | 1990 |
[Persisting alveolitis after Legionella pneumonia].
Topics: Adult; Antibodies, Bacterial; Biopsy; Chronic Disease; Drug Therapy, Combination; Erythromycin; Huma | 1990 |
Fatal pulmonary fibrosis from low-dose bleomycin therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Huma | 1987 |
Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos | 1987 |
Pulmonary emboli in patients receiving chemotherapy for non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; | 1988 |
Penicillamine for interstitial lung disease in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mid | 1989 |
Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis.
Topics: Adult; Aged; Cyclophosphamide; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Male; Myo | 1989 |
Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporins; Diagnosis, Differential; Graft v | 1989 |
Clinico-radiologic-pathologic conference: a patient with interstitial and airspace disease.
Topics: Bronchiolitis Obliterans; Diagnosis, Differential; Humans; Lung Diseases; Male; Middle Aged; Prednis | 1989 |
[Churg-Strauss syndrome].
Topics: Adult; Biopsy; Churg-Strauss Syndrome; Diagnosis, Differential; Female; Humans; Intestinal Mucosa; P | 1989 |
Association of activated cytolytic lung lymphocytes with response to prednisone therapy in patients with idiopathic pulmonary fibrosis.
Topics: Antibody-Dependent Cell Cytotoxicity; B-Lymphocytes; Bronchoalveolar Lavage Fluid; Humans; Lung; Lym | 1989 |
Sulfasalazine pneumonitis.
Topics: Angioedema; Colitis, Ulcerative; Desensitization, Immunologic; Drug Administration Schedule; Follow- | 1985 |
Sulfasalazine-induced pulmonary disease.
Topics: Aged; Colitis, Ulcerative; Humans; Male; Prednisone; Pulmonary Fibrosis; Respiratory Function Tests; | 1985 |
Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram.
Topics: Adult; Aged; Bronchiolitis Obliterans; Female; Humans; Lung; Lung Diseases; Male; Prednisone; Pulmon | 1989 |
Management for interstitial lung disease. State of the art.
Topics: Azathioprine; Biopsy; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Humans; Middle Aged; Prednison | 1989 |
Yellow nail syndrome.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lymphedema; Middle Aged; | 1986 |
Fat embolization and pulmonary infiltrates after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Embolism, Fat; Female; Humans; Leuke | 1987 |
Polymyositis with tubular aggregates.
Topics: Biopsy; Female; Humans; Microscopy, Electron; Middle Aged; Muscles; Myositis; Prednisone; Pulmonary | 1988 |
Angiotropic large cell lymphoma presenting as interstitial lung disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hemangioendot | 1988 |
Idiopathic pulmonary fibrosis.
Topics: Adult; Cyclophosphamide; Humans; Lung; Middle Aged; Prednisone; Pulmonary Fibrosis | 1988 |
Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies.
Topics: Adult; Antibodies, Antinuclear; Female; Humans; Lupus Erythematosus, Systemic; Prednisone; Pulmonary | 1988 |
Desquamative interstitial pneumonia. Computed tomographic findings before and after treatment with corticosteroids.
Topics: Adult; Biopsy; Humans; Lung; Male; Prednisone; Pulmonary Fibrosis; Tomography, X-Ray Computed | 1988 |
Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Cell Count; Female; Humans; Male; Middle Aged; Phosphatid | 1988 |
Lymphocytic interstitial pneumonia of common variable immunodeficiency.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Immunologic Deficiency Syndromes; Lung; Lym | 1988 |
Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease. A trial of N = 1.
Topics: Adult; Colitis, Ulcerative; Humans; Male; Prednisone; Pulmonary Fibrosis; Radiography; Respiratory F | 1988 |
The pathology and treatment of interstitial pneumonitis in two infants with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Humans; Infant; Male; Prednisone; Pulmonary Fibrosis | 1986 |
Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutrophils; | 1987 |
Sjögren's syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis.
Topics: Aged; Airway Obstruction; Female; Humans; Lymphoma; Prednisone; Pulmonary Fibrosis; Sjogren's Syndro | 1987 |
[Wegener's disease].
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Granulomatosis | 1987 |
Interstitial vasculitis--interstitial lung disease: case studies.
Topics: Adult; Aged; Azathioprine; Bronchodilator Agents; Female; Humans; Male; Middle Aged; Oxygen Consumpt | 1986 |
Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Prednison | 1986 |
Disseminated intravascular coagulation in lupus erythematosus responding to prednisone therapy.
Topics: Disseminated Intravascular Coagulation; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pr | 1986 |
Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy.
Topics: Bronchi; Humans; Lung; Prednisone; Pulmonary Alveoli; Pulmonary Fibrosis; Therapeutic Irrigation | 1987 |
[Gold-induced fibrosing alveolitis].
Topics: Arthritis, Rheumatoid; Dyspnea; Gold; Histocompatibility Antigens Class II; Humans; Male; Middle Age | 1985 |
Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis.
Topics: Aged; Bronchi; Female; Humans; Leukocyte Count; Male; Middle Aged; Neutrophils; Prednisone; Pulmonar | 1986 |
Desquamative interstitial pneumonia responsive to chloroquine.
Topics: Chloroquine; Drug Therapy, Combination; Humans; Infant, Newborn; Male; Prednisone; Pulmonary Alveoli | 1985 |
[Dermatopolymyositis and pulmonary fibrosis associated with Gougerot-Sjogren syndrome. Study of 3 cases].
Topics: Cyclophosphamide; Dermatomyositis; Female; Humans; Middle Aged; Prednisone; Pulmonary Alveoli; Pulmo | 1985 |
Spontaneous pneumothorax in cryptogenic fibrosing alveolitis.
Topics: Adult; Female; Humans; Male; Middle Aged; Pneumothorax; Prednisone; Pulmonary Diffusing Capacity; Pu | 1985 |
Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia.
Topics: Adult; Dyspnea; Erythromycin; Female; Humans; Pneumonia, Mycoplasma; Prednisone; Pulmonary Fibrosis | 1985 |
Lung transplantation in a patient with fibrosing alveolitis.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Dactinomycin; Graft Rejection; Humans; Immunosuppression | 1971 |
Prolonged immunological disorder terminating in hematological malignancy: A human analogue of animal disease?
Topics: Aged; Animal Diseases; Animals; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Blood Pr | 1970 |
Measles giant cell pneumonia in an adult following long-term chemotherapy.
Topics: Aged; Autopsy; Busulfan; Cell Nucleus; Chromatin; Diagnosis, Differential; Endothelium; Female; Huma | 1973 |
Pleuropulmonary manifestations of Waldenstrom's macroglobulinemia.
Topics: Aged; Chlorambucil; Female; Humans; Lung; Lung Diseases; Lymphocytes; Male; Middle Aged; Pleura; Ple | 1974 |
Idiopathic interstitial pulmonary fibrosis. An immune complex disease?
Topics: Antibodies, Antinuclear; Female; Fluorescent Antibody Technique; Humans; Immune Complex Diseases; Im | 1973 |
Steroid drugs in chest disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Asthma; Azathioprine; Humans; Hydrocortisone; | 1972 |
Distinctive ultrastructural findings in a case of idiopathic interstitial pneumonia.
Topics: Biopsy; Humans; Inclusion Bodies; Lung; Macrophages; Male; Microscopy, Electron; Middle Aged; Predni | 1972 |
Busulfan lung complicated by pneumocystis carinii and cytomegalovirus infection.
Topics: Busulfan; Cytarabine; Cytomegalovirus Infections; Female; Humans; Leukemia, Myeloid; Lung; Middle Ag | 1974 |
Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases.
Topics: Adult; Biopsy; Carbon Dioxide; Electromyography; Female; Humans; Lung; Microscopy, Electron; Muscles | 1974 |
[A case of interstitial lymphoid pneumonia treated with immunosuppressors].
Topics: Adult; Azathioprine; Carbon Dioxide; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosupp | 1974 |
Acquired von Willebrand's syndrome and systemic lupus erythematosus.
Topics: Blood Coagulation Disorders; Factor VIII; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; | 1972 |
[Alveolar proteinosis and marginal conditions].
Topics: Aged; Biopsy; Bronchoscopy; Diagnosis, Differential; Dyspnea; Electrocardiography; Humans; Hyaline M | 1974 |
Immunofluorescent staining of lung biopsy in fibrosing alveolitis.
Topics: Biopsy; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin | 1973 |
[Therapy of diffuse pulmonary fibrosis (including prevention of development and progression)].
Topics: Adrenal Cortex Hormones; Azathioprine; Biopsy; Bronchitis; Collagen Diseases; Humans; Immunosuppress | 1974 |
Desquamative interstitial pneumonia. Report of a case.
Topics: Aged; Autopsy; Humans; Male; Prednisone; Pulmonary Fibrosis; Radiography; Recurrence; Respiratory In | 1972 |
Pulmonary fibrosis masking polymyositis. Remission with corticosteroid therapy.
Topics: Aged; Dermatomyositis; Diagnosis, Differential; Humans; Male; Muscular Diseases; Prednisone; Pulmona | 1972 |
Desquamative interstitial pneumonia. New ultrastructural findings.
Topics: Adult; Endoplasmic Reticulum; Female; Humans; Lung; Prednisone; Pulmonary Alveoli; Pulmonary Fibrosi | 1973 |
Serial changes in scleroderma and idiopathic interstitial lung disease.
Topics: Adult; Aged; Arteries; Carbon Monoxide; Cyclophosphamide; Female; Humans; Lung Compliance; Male; Mer | 1973 |
Desquamative interstitial pneumonia. Case report of an infant unresponsive to treatment.
Topics: Autopsy; Biopsy; Chlorothiazide; Diuretics; Drug Resistance; Edema; Female; Hepatomegaly; Humans; In | 1973 |
[Therapy of idiopathic diffuse pulmonary fibrosis].
Topics: Adult; Aged; Azathioprine; Corticosterone; Female; Humans; Male; Middle Aged; Partial Pressure; Plet | 1973 |
[Steroid therapy in pulmonary sarcoidosis].
Topics: Humans; Lung Diseases; Lymph Nodes; Organ Size; Prednisone; Pulmonary Fibrosis; Recurrence; Sarcoido | 1973 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
Interstitial pneumonitis in association with polymyositis and dermatomyositis.
Topics: Adult; Aged; Biopsy; Dermatomyositis; Female; Humans; Lung; Male; Middle Aged; Myositis; Prednisone; | 1974 |
Pseudolymphoma of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Child; Female; Humans; Immunoglobulins; Immunosuppressive Agents | 1974 |
[Histiocytic reticulosis in infants or Letterer-Siwe disease. (Clinical and therapeutical study)].
Topics: Acrodermatitis; Betamethasone; Biopsy; Blood Cell Count; Bone Diseases; Child, Preschool; Chlorambuc | 1968 |
Polymyositis and interstitial lung disease.
Topics: Adult; Dermatomyositis; Female; Humans; Isoniazid; Middle Aged; Prednisone; Pulmonary Alveoli; Pulmo | 1972 |
Serial pulmonary function tests in fibrosing alveolitis.
Topics: Adult; Azathioprine; Biopsy; Dyspnea; Female; Humans; Lung; Male; Middle Aged; Prednisone; Pulmonary | 1972 |
[The development of a case of desquamative interstitial pneumonia into diffuse pulmonary fibrosis].
Topics: Autoantibodies; Biopsy; Blood Pressure Determination; Capillaries; Cyanosis; Humans; Infant, Newborn | 1971 |
The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs.
Topics: Adult; Agglutination Tests; Antibodies, Antinuclear; Azathioprine; Chlorambucil; Complement Fixation | 1971 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1971.
Topics: Autopsy; Biopsy; Busulfan; Cell Nucleus; Cervix Uteri; Diagnosis, Differential; Epithelium; Female; | 1971 |
A case of desquamative interstitial pneumonia.
Topics: Adult; Biopsy; Bronchitis; Cough; Diagnosis, Differential; Follow-Up Studies; Humans; Lung; Male; Pn | 1970 |
Desquamative interstitial pneumonia. An electron microscopic study.
Topics: Biopsy; Cyanosis; Dyspnea; Humans; Macrophages; Male; Microscopy, Electron; Middle Aged; Osteoarthro | 1970 |
Corticosteroid treatment of diffuse interstitial pulmonary fibrosis.
Topics: Adult; Biopsy; Blood Gas Analysis; Humans; Lung; Male; Prednisone; Pulmonary Fibrosis; Radiography; | 1970 |
Desquamative interstitial pneumonia in a 7-week-old infant.
Topics: Anti-Bacterial Agents; Biopsy; Blood Cell Count; Eosinophils; Humans; Infant; Lung; Male; Prednisone | 1970 |
Desquamative interstitial pneumonia in children. Report of two cases.
Topics: Biopsy; Child; Female; Humans; Lung; Male; Osteoarthropathy, Secondary Hypertrophic; Prednisone; Pul | 1970 |
Desquamative interstitial pneumonia.
Topics: Biopsy; Humans; Infant; Male; Prednisone; Pulmonary Alveoli; Pulmonary Fibrosis; Radiography | 1971 |
Generalized paraffinoma (sclerosing lipogranuloma).
Topics: Adipose Tissue; Adult; Embolism, Fat; Female; Granuloma; Humans; Leg; Mineral Oil; Prednisone; Pulmo | 1971 |
[Diffuse interstitial pulmonary fibrosis (Hamman-Rich syndrome) and primary chronic polyarthritis].
Topics: Adult; Arthritis, Rheumatoid; Chloroquine; Chronic Disease; Female; Humans; Oxytetracycline; Phospha | 1971 |
Lung involvement in polymyositis.
Topics: Biopsy; Dermatomyositis; Diagnosis, Differential; Humans; Male; Middle Aged; Prednisone; Pulmonary F | 1971 |
Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis.
Topics: Adult; Aged; Aspartate Aminotransferases; Diagnosis, Differential; Female; Humans; Isoniazid; L-Lact | 1968 |
Nitrofurantoin sensitivity. Report of a child with chronic inflammatory lung disease.
Topics: Child; Drug Hypersensitivity; Female; Humans; Nitrofurantoin; Prednisone; Pulmonary Fibrosis; Radiog | 1968 |
[Our experiences with treatment of chronic interstitial pneumonia of the Hamman-Rich syndrome in children].
Topics: Adolescent; Adult; Child; Child, Preschool; Chloroquine; Dexamethasone; Female; Follow-Up Studies; G | 1968 |
Pulmonary reaction to nitrofurantoin.
Topics: Humans; Nitrofurantoin; Prednisone; Pulmonary Fibrosis; Radiography; Respiratory Function Tests | 1969 |
[Hamman-Rich syndrome. Report of a case under steroid therapy].
Topics: Adult; Humans; Male; Prednisone; Pulmonary Fibrosis | 1965 |
Idiopathic pulmonary haemosiderosis with myocarditis. Radio-isotope studies in a patient treated with prednisone.
Topics: Adolescent; Hemoptysis; Hemosiderosis; Humans; Iron Isotopes; Lung Diseases; Male; Myocarditis; Pred | 1966 |
[Pulmonary complication during hematologic remission of acute leukemia in children. A report on 5 cases].
Topics: Adolescent; Adrenal Cortex Hormones; Aminopyrine; Blood; Blood Cell Count; Blood Transfusion; Capill | 1966 |
[Spirographic control of prednisone action in diffuse pulmonary fibrosis and other lung parenchymal diseases].
Topics: Child; Child, Preschool; Female; Hemosiderosis; Humans; Lung Diseases; Lupus Erythematosus, Systemic | 1966 |